{"title":"Cell Lines","description":"\u003cp\u003e\u003cstrong\u003eBetter Reporter Expression\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eOur stable reporter cell lines are generated by high-efficiency lentivirus transduction; the reporter gene is integrated in the target cell genome, facilitating stable reporter expression during continued passaging. Our polyclonal cell lines couple our reporter genes to an antibiotic selection gene (either puromycin or neomycin) to ensure that the population is comprised of high reporter-expressing cells. Our monoclonal cell lines undergo several rounds of selection to optimize high reporter gene expression. Reporter gene expression in each of our reporter cell lines is driven by the spleen focus-forming virus (SFFV) promoter, which results in high constitutive expression in a wide range of mammalian cells and mouse models. Thus, our stable reporter cell lines are perfectly suited for \u003cem\u003ein vivo\u003c\/em\u003e imaging studies, where the high reporter gene expression facilitates detection of fewer implanted cells. \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMulti-Modality Imaging\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImanis offers more options for \u003cem\u003ein vivo\u003c\/em\u003e imaging due to our unique selection of reporter genes. Our cancer cell models are available with one, or a combination, of our four main reporters: enhanced green fluorescent protein (eGFP), firefly luciferase (Fluc), near-infrared fluorescent protein (iRFP), or the sodium-iodide symporter (NIS). These reporters offer the flexibility to choose the imaging modality that will best meet your needs and equipment, whether it be intravital or conventional microscopy using eGFP, noninvasive in-life imaging using Fluc or iRFP, or noninvasive, high-resolution 3D PET\/SPECT imaging using NIS. \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHighest Quality Cells\u003c\/strong\u003e \u003c\/p\u003e\n\u003cp\u003eOur cell lines undergo extensive quality control analyses so that you can choose Imanis with confidence. In addition to ensuring sterility, each cell line undergoes rigorous testing for reporter gene expression, so you get only the best reporter-expressing cell lines. All of our cell lines are certified mycoplasma free. Moreover, our parental cell lines are authenticated with short tandem repeat (STR) profiling, in accordance with recommendations by the NIH as well as several other funding organizations and major publishers (footnote). \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFootnote:\u003c\/strong\u003e It has been estimated that ~18-36% of cell lines utilized in biomedical research are contaminated or completely misidentified (Hughes et al., BioTechniques 2007). Consequently, verification of cell line identity is of critical significance. Several funding organizations, including the NIH, and major publishers, such as those affiliated with the American Association for Cancer Research (AACR), have established requirements for cell line authentication prior to publication.\u003c\/p\u003e","products":[{"product_id":"cl017","title":"Mel624-CMV-hNIS-Neo\/eGFP-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Human-Line\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman\u003c\/a\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Melanoma\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMelanoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/pages\/what-is-nis\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman sodium iodide symporter (hNIS)\u003c\/a\u003e with neomycin resistance (Neo) for selection with G418 and enhanced green fluorescent protein (eGFP) with puromycin resistance (puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 0.4mg\/mL G418, 1ug\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e \u003cstrong\u003eDescription: \u003c\/strong\u003eMel624-CMVhNIS-Neo\/eGFP-Puro is a polyclonal population of the human melanoma Mel624 cell line transduced with a lentiviral vector encoding the human sodium iodide symporter (hNIS) cDNA under the cytomegalovirus (CMV) promoter linked to the neomycin resistance gene via an IRES and \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e encoding enhanced green fluorescent protein (eGFP) under the spleen focus-forming virus (SFFV) promoter and puromycin resistance (Puro) under the PGK promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high hNIS\/eGFP expressing clone suitable for use as a positive control cell line in I-125 uptake assays to validate NIS expression and fluorescence assays to validate GFP expression in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: This human melanoma cell line grows as subcutaneous xenografts in aythmic nude mice and its growth can be monitored noninvasively using high-resolution 3D SPECT or PET imaging. \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003ePublications that used associated reagents: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e: Shen et al. Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=26712908\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eBlood. 2016. March 17: 127(11): 1449-58\u003c\/a\u003e.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_large.png?11787898939869210910\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNIS Function Assay (Iodine Uptake):\u003c\/strong\u003e Cells were incubated with \u003csup\u003e125\u003c\/sup\u003eI for 1h in the presence or absence of KClO\u003csub\u003e4\u003c\/sub\u003e, an inhibitor of iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/I125_uptake_for_COA_large.jpg?3362860445947339673\" alt=\"\"\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFlow Cytometry for eGFP: \u003c\/strong\u003eMel624-CMVhNIS-Neo\/eGFP-Puro (green) or control (grey) cells were fixed with paraformaldehyde and analyzed by flow cytometry (20,000 events).\u003c\/p\u003e\n\u003cp style=\"padding-left: 30px;\"\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/FACS_large.png?5560520481701439184\" alt=\"\" width=\"302\" height=\"298\"\u003e\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15996315795528,"sku":"CL017-STAN","price":2100.0,"currency_code":"USD","in_stock":true}]},{"product_id":"cl005","title":"HCT116-hNIS-Neo","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Human-Line\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/colorectal-cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eColorectal carcinoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/pages\/what-is-nis\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman sodium iodide symporter (hNIS)\u003c\/a\u003e with neomycin resistance (Neo) for selection with G418\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 0.5 mg\/mL G418\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eHCT116-hNIS-Neo is a polyclonal population of the human colorectal carcinoma cell line HCT116 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CCL-247.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CCL-247™)\u003c\/a\u003e transduced with \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv013\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-hNIS-Neo (LV013)\u003c\/a\u003e encoding the human sodium iodide symporter (hNIS) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene (Neo) via an IRES.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMycoplasma Testing:\u003c\/strong\u003e This cell line has been tested for mycoplasma contamination and is certified mycoplasma free.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eAuthentication of the parental HCT116 cell line was performed by short tandem repeat (STR) profiling with 9 STR loci including CSF1PO, D13S317, D16S539, D5S818, D7S820, TH01, TPOX, vWA and sex chromosome marker \u003cem\u003eAmelogenin\u003c\/em\u003e. STR profiling of HCT116 cells are verified and there is no interspecies cross contamination detected.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high hNIS expressing clone suitable for use as a positive control cell line in I-125 uptake assays to validate NIS expression in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: This human colorectal cell line grows as xenografts in immunocompromised mice. Growth of the tumors can be monitored using SPECT or PET imaging.\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Cell_Photos_for_COA_CL005_large.jpg?1716019334555915035\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNIS Function Assay (Iodine Uptake):\u003c\/strong\u003e Cells were incubated with \u003csup\u003e125\u003c\/sup\u003eI for 1h in the presence or absence of KClO\u003csub\u003e4\u003c\/sub\u003e, an inhibitor of iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/I-125_uptake_CL005_large.png?7796796910352333982\" alt=\"\"\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15996282568776,"sku":"CL005-STAN","price":1500.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Cell_Photos_for_COA_CL005.jpg?v=1467242873"},{"product_id":"cl008","title":"HCT116-Fluc-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Human-Line\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/colorectal-cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eColorectal carcinoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Firefly luciferase (Fluc) with puromycin resistance for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 1 μg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHCT116-Fluc-Puro is a polyclonal population of the human colorectal carcinoma cell line HCT116 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CCL-247.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CCL-247™)\u003c\/a\u003e transduced with \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv012\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-Fluc-P2A-Puro (LV012)\u003c\/a\u003e encoding firefly luciferase (Fluc) cDNA under the SFFV promoter linked to the puromycin resistance gene (Puro) via a P2A cleavage peptide.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMycoplasma Testing: \u003c\/strong\u003eThis cell line has been tested for mycoplasma contamination and is certified mycoplasma free.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAuthentication of the parental HCT116 cell line was performed by short tandem repeat (STR) profiling with 9 STR loci including CSF1PO, D13S317, D16S539, D5S818, D7S820, TH01, TPOX, vWA and sex chromosome marker \u003cem\u003eAmelogenin\u003c\/em\u003e. STR profiling of HCT116 cells are verified and there is no interspecies cross contamination detected.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high Fluc expressing clone suitable for use as a positive control cell line in bioluminescence assays to validate luciferase expression in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: This human colorectal cell line grows as xenografts in immunocompromised mice. Growth of these tumors can be monitored noninvasively using bioluminescent imaging with D-luciferin substrate.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_CL008_large.png?9783866168007657492\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLuciferase Assay: \u003c\/strong\u003e10\u003csup\u003e4\u003c\/sup\u003e, 10\u003csup\u003e5\u003c\/sup\u003e, or 10\u003csup\u003e6\u003c\/sup\u003e cells were placed in wells of a 96-well plate and 0.3 mg of d-luciferin was added to the indicated wells. The plate was immediately imaged using a Xenogen IVIS Spectrum.\u003c\/p\u003e\n\u003cp style=\"padding-left: 30px;\"\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Xenogen_for_website_CL008_large.png?9030497599628898154\" alt=\"\"\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBioluminescent images of a subcutaneous HCT116-Fluc-Puro tumor in an athymic mouse\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/CL008_4772_Web_image_HCT116_large.png?v=1460939560\" alt=\"\" width=\"360\" height=\"280\"\u003e\u003c\/p\u003e\n\u003ch5\u003e10\u003csup\u003e7\u003c\/sup\u003e HCT116-Fluc-Puro cells (\u003ca href=\"https:\/\/www.imanislife.com\/products\/cl008\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eImanis Life catalog #CL008\u003c\/a\u003e) were injected subcutaneously into the right flanks of female NCR athymic mice. Mice were imaged at day 0 on the day of cell implantation and at days 7 and 16 using a Perkin Elmer IVIS® Spectrum system, at 10-15 minutes post intraperitoneal injection of D-luciferin at 150 mg\/kg. Tumor size was measured using calipers. Data from a representative mouse (ID#4772) is shown.\u003c\/h5\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15996281159752,"sku":"CL008-STAN","price":1500.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL008.png?v=1467242867"},{"product_id":"cl009","title":"HCT116-hNIS-Neo\/Fluc-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Human-Line\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/colorectal-cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eColorectal carcinoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/pages\/what-is-nis\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman sodium iodide symporter (hNIS)\u003c\/a\u003e with neomycin resistance (Neo) for selection with G418 and firefly luciferase (Fluc) with puromycin resistance for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 0.5 mg\/mL G418, 1 μg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eHCT116-hNIS-Neo\/Fluc-Puro is a polyclonal population of the human colorectal carcinoma cell line HCT116 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CCL-247.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CCL-247™)\u003c\/a\u003e transduced with 1) \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv013\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-hNIS-Neo (LV013)\u003c\/a\u003e encoding the human sodium iodide symporter (hNIS) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene (Neo) via an IRES and 2) \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv012\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-Fluc-P2A-Puro (LV012)\u003c\/a\u003e encoding firefly luciferase (Fluc) cDNA under the SFFV promoter linked to the puromycin resistance gene (Puro) via a P2A cleavage peptide.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMycoplasma Testing: \u003c\/strong\u003eThis cell line has been tested for mycoplasma contamination and is certified mycoplasma free.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eAuthentication of the parental HCT116 cell line was performed by short tandem repeat (STR) profiling with 9 STR loci including CSF1PO, D13S317, D16S539, D5S818, D7S820, TH01, TPOX, vWA and sex chromosome marker \u003cem\u003eAmelogenin\u003c\/em\u003e. STR profiling of HCT116 cells are verified and there is no interspecies cross contamination detected.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high hNIS\/Fluc expressing clone suitable for use as a positive control cell line in iodine uptake assays and bioluminescence assays to validate NIS or luciferase expression respectively in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: This human colorectal cell line grows as xenografts in immunocompromised mice. Growth of these tumors can be monitored using noninvasive high-resolution 3D SPECT or PET imaging or bioluminescent imaging using D-luciferin substrate.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_CL009_large.png?3039675333175159333\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNIS Function Assay (Iodine Uptake):\u003c\/strong\u003e Cells were incubated with \u003csup\u003e125\u003c\/sup\u003eI for 1h in the presence or absence of KClO\u003csub\u003e4\u003c\/sub\u003e, an inhibitor of iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Uptake_for_COA_IM46_large.jpg?12150647913893959517\" alt=\"\" width=\"411\" height=\"252\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLuciferase Assay: \u003c\/strong\u003e10\u003csup\u003e4\u003c\/sup\u003e, 10\u003csup\u003e5\u003c\/sup\u003e, or 10\u003csup\u003e6\u003c\/sup\u003e cells were placed in wells of a 96-well plate and 0.3 mg of d-luciferin was added to the indicated wells. The plate was immediately imaged using a Xenogen IVIS Spectrum.\u003c\/p\u003e\n\u003cp style=\"padding-left: 30px;\"\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Xenogen_for_website_CL009_large.png?895379044084503171\" alt=\"\" width=\"442\" height=\"152\" style=\"line-height: 1.4;\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBioluminescent images of a subcutaneous HCT116-Fluc-Puro tumor in an athymic mouse\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/CL008_4772_Web_image_HCT116_large.png?v=1460939560\" alt=\"\" width=\"360\" height=\"280\"\u003e\u003c\/p\u003e\n\u003ch5\u003e10\u003csup\u003e7\u003c\/sup\u003e HCT116-Fluc-Puro cells (\u003ca href=\"https:\/\/www.imanislife.com\/products\/cl008\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eImanis Life catalog #CL008\u003c\/a\u003e) were injected subcutaneously into the right flanks of female NCR athymic mice. Mice were imaged at day 0 on the day of cell implantation and at days 7 and 16 using a Perkin Elmer IVIS® Spectrum system, at 10-15 minutes post intraperitoneal injection of D-luciferin at 150 mg\/kg. Tumor size was measured using calipers. Data from a representative mouse (ID#4772) is shown.\u003c\/h5\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15996281716808,"sku":"CL009-STAN","price":2100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/CL008_4772_Web_image_HCT116.png?v=1466608477"},{"product_id":"cl026","title":"A549-hNIS-Neo\/eGFP-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Human-Line\"\u003eHuman\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Lung-Cancer\"\u003eLung carcinoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/pages\/what-is-nis\"\u003eHuman sodium iodide symporter (hNIS)\u003c\/a\u003e with neomycin resistance (Neo) for selection with G418 and enhanced green fluorescent protein (eGFP) with puromycin resistance (Puro) for selection with puromycin.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 0.6 mg\/mL G418\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eA549-hNIS-Neo\/GFP-Puro is a polyclonal population of the human lung carcinoma cell line A549 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CCL-185.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CCL-185™)\u003c\/a\u003e transduced with \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv013\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-hNIS-Neo (LV013)\u003c\/a\u003e encoding the human sodium iodide symporter (hNIS) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene via an IRES and \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e encoding enhanced GFP under the SFFV promoter and puromycin resistance under the PGK promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vectors used are self-inactivating (SIN) vectors in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eThe parental A549 cell line was authenticated and certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 9 STR loci including CSF1PO, D13S317, D16S539, D5S818, D7S820, TH01, TPOX, vWA and sex chromosome marker Amelogenin.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high hNIS\/eGFP expressing clone suitable for use as a positive control cell line in I-125 uptake assays to validate NIS expression and fluorescence assays to validate GFP expression in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: A549 cells form metastases in the lungs of mice post systemic administration. The in vivo growth of these metastases can be monitored noninvasively in animals using SPECT or PET imaging. They can also be observed via optical imaging of eGFP fluorescence.\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003eNote\u003c\/span\u003e: In-life imaging for GFP fluorescence is not recommended due to high background autofluorescence and low light penetration. Tissues may be harvested post mortem for analysis by conventional microscopy\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications that used associated reagents: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e: Shen et al. Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=26712908\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eBlood. 2016. March 17: 127(11): 1449-58\u003c\/a\u003e. \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_COA_IM09_large.png?4681383458534287319\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgene Validation:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNIS Functional Assay\u003c\/strong\u003e (Iodine Uptake): Cells were incubated with I-125 for 1h in the presence or absence of KClO4, an inhibitor of NIS-mediated iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter.\u003c\/p\u003e\n\u003cp\u003e \u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Uptake_Data_for_COA_IM09_large.jpg?2552443605105363504\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFlow Cytometry for eGFP:\u003c\/strong\u003e A549-hNIS-Neo\/eGFP-Puro (green) or control (A549-hNIS-Neo; grey) cells were fixed with paraformaldehyde and analyzed by flow cytometry (20,000 events).\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/FACS_results_large.jpg?15721886156243001640\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15985273765960,"sku":"CL026-STAN","price":2100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_COA_IM09.png?v=1467242809"},{"product_id":"cl018","title":"HEK293-hNIS-eGFP","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.imanislife.com\/collections\/cell-lines\/Human-Lines\" target=\"_blank\" title=\"human cancer cell lines from ATCC expressing reporter genes for multimodality imaging fluorescence bioluminescence SPECT PET\" rel=\"noopener noreferrer\"\u003eHuman\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e Epithelial embryonic kidney\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Human \u003ca href=\"https:\/\/www.imanislife.com\/pages\/what-is-nis\" target=\"_blank\" title=\"NIS reporter gene sodium iodide symporter high resolution 3D in vivo imaging\" rel=\"noopener noreferrer\"\u003esodium iodide symporter\u003c\/a\u003e (mNIS) and enhanced green fluorescent protein (eGFP)\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eHEK293-hNIS-GFP is a polyclonal population of the human embryonic kidney HEK293 cell line transduced with a lentiviral vector LV-hNIS-IRES-eGFP encoding the human sodium iodide symporter (hNIS) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the emerald green fluorescent protein (GFP) gene via an IRES (new Imanis item catalog \u003ca href=\"https:\/\/www.imanislife.com\/products\/lv020\" target=\"_blank\" title=\"lentiviral vector hNIS and eGFP\" rel=\"noopener noreferrer\"\u003e#LV020\u003c\/a\u003e, LV-eGFP-P2A-hNIS).\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMycoplasma Testing: \u003c\/strong\u003eThis cell line has been tested for mycoplasma contamination and is certified mycoplasma free.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This high NIS expressing cell line can be used as a positive control for I-125 uptake assays to validate NIS expression in your lentiviral transduced cells.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eGFP Fluorescence:\u003c\/strong\u003e\u003cspan\u003e Cell morphology and flow cytometry to confirm high GFP expression in cells.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Fluorescence_for_COA_large.JPG?v=1460914266\" alt=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNIS Function Assay (Iodine Uptake):\u003c\/strong\u003e Cells were incubated with \u003csup\u003e125\u003c\/sup\u003eI for 1h in the presence or absence of KClO\u003csub\u003e4\u003c\/sub\u003e, an inhibitor of iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/I125_uptake_for_COA_large.JPG?v=1460914266\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15996283781192,"sku":"CL018-STAN","price":2100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Fluorescence_for_COA.JPG?v=1466613068"},{"product_id":"cl004","title":"A549-hNIS-Neo","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003cspan\u003e\u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Human-Line\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003cspan\u003e\u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Lung-Cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLung carcinoma\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e \u003cspan\u003e\u003ca href=\"http:\/\/www.imanislife.com\/pages\/what-is-nis\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman sodium iodide symporter (hNIS)\u003c\/a\u003e\u003c\/span\u003e, neomycin resistance (Neo) for selection with G418\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 0.6 mg\/mL G418\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eA549-hNIS-Neo is a polyclonal population of the human lung carcinoma cell line A549 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CCL-185.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CCL-185™)\u003c\/a\u003e transduced with \u003ca href=\"www.imanislife.com\/products\/lv013\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-hNIS-Neo (LV013)\u003c\/a\u003e encoding the human sodium iodide symporter (hNIS) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene via an IRES. \u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eThe parental A549 cell line was authenticated and certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 9 STR loci including CSF1PO, D13S317, D16S539, D5S818, D7S820, TH01, TPOX, vWA and sex chromosome marker Amelogenin.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high hNIS expressing clone suitable for use as a positive control cell line in I-125 uptake assays to validate NIS expression in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: A549 cells form metastases in the lungs of mice post systemic administration. The in vivo growth of these metastases can be monitored noninvasively in animals using SPECT or PET imaging.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low and high density cell morphology (200x)\u003c\/p\u003e\n\u003cp style=\"text-align: left;\"\u003e\u003cimg alt=\"\" src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Cell_Photos_for_COA_CL004_large.jpg?v=1454624439\" style=\"float: none;\"\u003e\u003cstrong\u003eTransgene Validation:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNIS Functional Assay\u003c\/strong\u003e (Iodine Uptake): Cells were incubated with I-125 for 1h in the presence or absence of KClO4, an inhibitor of NIS-mediated iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/I125_uptake_for_COA_CL004_large.jpg?704328459278938117\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15985240047688,"sku":"CL004-STAN","price":1500.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Cell_Photos_for_COA_CL004.jpg?v=1466612985"},{"product_id":"cl001","title":"Mel624-CMV-hNIS-Neo","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.imanislife.com\/collections\/cell-lines\/Human-Lines\" title=\"Human cancer cell lines ATCC derived with reporter genes bioluminescence fluorescence SPECT PET imaging\"\u003eHuman\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type: \u003c\/strong\u003e\u003ca href=\"https:\/\/www.imanislife.com\/collections\/cell-lines\/Melanoma\" target=\"_blank\" title=\"Melanoma cells reporter genes\" rel=\"noopener noreferrer\"\u003eMelanoma\u003c\/a\u003e\u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Melanoma\"\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Human \u003ca href=\"https:\/\/www.imanislife.com\/pages\/what-is-nis\" target=\"_blank\" rel=\"noopener noreferrer\"\u003esodium iodide symporter\u003c\/a\u003e (hNIS) with\u003cstrong\u003e \u003c\/strong\u003eneomycin resistance (Neo) for selection with G418\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 0.4mg\/mL G418 \u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eMel624-CMVhNIS-Neo is a \u003cstrong\u003emonoclonal population\u003c\/strong\u003e of the human melanoma Mel624 cell line transduced with a lentiviral vector encoding the \u003cspan style=\"color: #000000;\"\u003ehuman sodium iodide symporter (hNIS\u003c\/span\u003e) cDNA under the cytomegalovirus (CMV) promoter linked to the neomycin resistance gene via an IRES.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended Uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high hNIS expressing clone suitable for use as a positive control cell line in I-125 uptake assays to validate NIS expression in your lentiviral transduced cells. \u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: This human melanoma cell line grows as subcutaneous xenografts in aythmic nude mice and its growth can be monitored noninvasively using high-resolution 3D SPECT or PET imaging.\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology: \u003c\/strong\u003eLow and high density cell morphology (200X)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Cropped_cell_photos_for_COA_CL001_large.jpg?18020079903047576781\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNIS Function Assay (Iodine Uptake):\u003c\/strong\u003e Cells were incubated with \u003csup\u003e125\u003c\/sup\u003eI for 1h in the presence or absence of KClO\u003csub\u003e4\u003c\/sub\u003e, an inhibitor of iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/I125_uptake_for_COA_CL001_large.jpg?14484285810823171546\" alt=\"\" style=\"line-height: 1.4;\"\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15996312617032,"sku":"CL001-STAN","price":1500.0,"currency_code":"USD","in_stock":true}]},{"product_id":"cl048","title":"Mel624-hNIS-Neo","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.imanislife.com\/collections\/cell-lines\/Human-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Melanoma\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMelanoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/pages\/what-is-nis\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman sodium iodide symporter (hNIS)\u003c\/a\u003e with neomycin resistance (Neo) for selection with G418\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 0.25mg\/mL G418\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eMel624-hNIS-Neo is a monoclonal population of the human melanoma Mel624 cell line transduced with \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv013\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-hNIS-Neo (LV013)\u003c\/a\u003e encoding the human sodium iodide symporter (hNIS) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene via an IRES.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high hNIS expressing clone suitable for use as a positive control cell line in iodine uptake assays to validate NIS expression in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: This human melanoma cell line grows as subcutaneous xenografts in aythmic nude mice and its growth can be monitored noninvasively using high-resolution 3D SPECT or PET imaging.\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology\u003c\/strong\u003e: Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_CL048_large.png?15455672491956953237\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNIS Function Assay (Iodine Uptake):\u003c\/strong\u003e Cells were incubated with \u003csup\u003e125\u003c\/sup\u003eI for 1h in the presence or absence of KClO\u003csub\u003e4\u003c\/sub\u003e, an inhibitor of iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/I125_uptake_for_COA_CL048_large.jpg?11620627825584712798\" alt=\"\"\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15996319006792,"sku":"CL048-STAN","price":1500.0,"currency_code":"USD","in_stock":true}]},{"product_id":"cl021","title":"4T1-eGFP-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Line\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Breast-Cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMammary carcinoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Enhanced green fluorescent protein (eGFP) and puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e RPMI, 10% FBS, 1% Pen\/Strep, 2 ug\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e4T1-eGFP-Puro is a polyclonal population of the murine mammary carcinoma cell line 4T1 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-2539.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CRL-2539™)\u003c\/a\u003e transduced with \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e encoding enhanced green fluorescent protein (eGFP) cDNA under the spleen focus-forming virus (SFFV) promoter and the puromycin resistance gene under control of the PGK promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe parental 4T1 cell line was authenticated and cells are certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 27 STR loci. \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high eGFP expressing cell line suitable for use as a positive control cell line to verify GFP expression in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: 4T1 cells form tumors post implantation into immunocompromised or syngenic Balb\/c mice. These tumors can be detected using optical imaging for GFP fluorescence at post mortem analysis.\u003c\/p\u003e\n\u003cp\u003eNote: In-life imaging for GFP fluorescence is not recommended due to high background autofluorescence and low light penetration. Tissues may be harvested post mortem for analysis by conventional microscopy. For\u003cem\u003e\u003cstrong\u003e in vivo\u003c\/strong\u003e\u003c\/em\u003e imaging, please use luciferase or the nonimmunogenic murine NIS reporter gene.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eCell morphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg alt=\"Normal 4T1 morphology in 4T1-eGFP-Puro cells, high GFP expression\" src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Pics_for_website_CL021_large.png?8937995574085875971\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgene Validation:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFlow cytometry of 4T1-eGFP-Puro (green) and an isotype control (gray)\u003c\/p\u003e\n\u003cp style=\"text-align: left;\"\u003e\u003cimg alt=\"Flow cytometry for GFP shows high GFP expression in 4t1-eGFP-Puro cells\" src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Flow_for_website_CL021_large.png?2778394058972426112\" style=\"float: none;\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications that used associated reagents: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e: Shen et al. Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=26712908\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eBlood. 2016. March 17: 127(11): 1449-58\u003c\/a\u003e. \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15981512622152,"sku":"CL021-STAN","price":1500.0,"currency_code":"USD","in_stock":true}]},{"product_id":"cl044","title":"CT26.WT-eGFP-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Colorectal-Cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eColorectal Cancer\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Enhanced green fluorescent protein (eGFP) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 3 μg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eCT26.WT-eGFP-Puro is a polyclonal population of the murine colorectal carcinoma cell line CT26.WT \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-2638.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CRL-2638™)\u003c\/a\u003e transduced with \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e encoding enhanced green fluorescent protein (eGFP) cDNA under the spleen focus-forming virus (SFFV) promoter and the puromycin resistance gene (Puro) under control of the PGK promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eAuthentication of the parental CT26.WT cell line was performed by short tandem repeat (STR) profiling with 27 STR loci. STR profiling of CT26.WT cells are verified and there is no interspecies cross contamination detected.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high eGFP expressing cell line suitable for use as a positive control cell line in fluorescence assays to verify GFP expression in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: CT26.WT cells form tumors post implantation into immunocompromised or Balb\/c syngeneic mice. \u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003eNote\u003c\/span\u003e: In-life imaging for GFP fluorescence is not recommended due to high background autofluorescence. Tissues may be harvested post mortem for analysis by conventional microscopy. For in vivo imaging in immunocompetent animals, please consider using the nonimmunogenic murine \u003ca href=\"https:\/\/www.imanislife.com\/pages\/what-is-nis\"\u003eNIS reporter gene\u003c\/a\u003e.\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003ePublications that used associated reagents: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e: Shen et al. Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=26712908\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eBlood. 2016. March 17: 127(11): 1449-58\u003c\/a\u003e.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Pics_for_website_CL044_large.png?18134456867212819952\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgene Validation:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFlow cytometry of CT26.WT-GFP-Puro (green) and control CT26.WT (grey) cells.\u003c\/p\u003e\n\u003cp style=\"text-align: left;\"\u003e\u003cimg alt=\"\" src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/FACS_CL044_large.jpg?16474493977322578778\" style=\"float: none;\" width=\"417\" height=\"413\"\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15990795796552,"sku":"CL044-STAN","price":1500.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Pics_for_website_CL044.png?v=1467242846"},{"product_id":"cl043","title":"CT26.WT-Fluc-Neo","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies: \u003c\/strong\u003e\u003ca href=\"https:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Colorectal-Cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eColorectal Cancer\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Firefly luciferase (Fluc) with neomycin resistance (Neo) for selection with G418\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 0.4mg\/mL G418\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eCT26.WT-Fluc-Neo is a polyclonal population of the murine colorectal carcinoma cell line CT26.WT \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-2638.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CRL-2638™)\u003c\/a\u003e transduced with \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv011\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-Fluc-P2A-Neo (LV011)\u003c\/a\u003e encoding firefly luciferase (Fluc) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene (Neo) via a P2A cleavage peptide.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eAuthentication of the parental CT26.WT cell line was performed by short tandem repeat (STR) profiling with 27 STR loci. STR profiling of CT26.WT cells are verified and there is no interspecies cross contamination detected.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high Fluc expressing cell line suitable for use as a positive control cell line in bioluminescence assays to verify luciferase expression in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: CT26.WT cells form tumors post implantation into syngenic Balb\/c mice. The in vivo growth of these metastases can be monitored using bioluminescent imaging with D-luciferin substrate.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eCell Morphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_CL043_large.png?10540925926031682590\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgene Validation:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLuciferase assay\u003c\/strong\u003e: 10\u003csup\u003e4\u003c\/sup\u003e-10\u003csup\u003e6\u003c\/sup\u003e cells were placed in wells of a 96-well plate and 0.3 mg of d-luciferin was added to the indicated wells. The plate was immediately imaged using a \u003cspan\u003ePerkin Elmer IVIS® Spectrum system\u003c\/span\u003e. \u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Xenogen_for_website_CL043_large.png?8171021592024698811\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBioluminescent images showing growth of a subcutaneous CT26.WT-Fluc tumor in an athymic mouse\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/CL043_IM70_Web_large.png?v=1460738256\" alt=\"\" width=\"352\" height=\"302\"\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch5\u003e10\u003csup\u003e7\u003c\/sup\u003e CT26.WT-Fluc-Neo cells were injected subcutaneously into the right flanks of female NCR athymic mice. Mice were imaged at day 0 on the day of cell implantation and subsequently at days 7 and 11 using a Perkin Elmer IVIS® Spectrum system, at 10-15 minutes post intraperitoneal injection of D-luciferin at 150 mg\/kg. Tumor size was measured using calipers. Data from a representative mouse (ID#5815) is shown.\u003c\/h5\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15990783737928,"sku":"CL043-STAN","price":1500.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/CL043_IM70_Web.png?v=1466608538"},{"product_id":"cl046","title":"CT26.WT-Fluc-Neo\/eGFP-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Colorectal-Cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eColorectal C\u003c\/a\u003e\u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Colorectal-Cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eancer\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Firefly luciferase (Fluc) with neomycin resistance (Neo) for selection with G418 and enhanced green fluorescent protein (eGFP) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 0.7mg\/mL G418, 10μg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eCT26.WT-mNIS-Neo\/eGFP-Puro is a polyclonal population of the murine colorectal carcinoma cell line CT26.WT \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-2638.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CRL-2638™)\u003c\/a\u003e transduced with 1) \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv011\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-Fluc-P2A-Neo (LV011)\u003c\/a\u003e encoding firefly luciferase (Fluc) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene (Neo) via a P2A cleavage peptide and 2) \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e encoding enhanced green fluorescent protein (eGFP) cDNA under the spleen focus-forming virus (SFFV) promoter and the puromycin resistance gene (Puro) under control of the PGK promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eAuthentication of the parental CT26.WT cell line was performed by short tandem repeat (STR) profiling with 27 STR loci. STR profiling of CT26.WT cells are verified and there is no interspecies cross contamination detected.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high Fluc\/eGFP expressing cell line suitable for use as a positive control cell line in bioluminescence assays and fluorescence assays to verify luciferase or GFP expression respectively in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: CT26.WT cells form tumors post implantation into immunocompromised or syngenic Balb\/c mice. The in vivo growth of these metastases can be monitored using bioluminescent imaging with D-luciferin substrate or optical imaging for GFP fluorescence.\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003eNote\u003c\/span\u003e: In-life imaging for GFP fluorescence is not recommended due to high background autofluorescence. Tissues may be harvested post mortem for analysis by conventional microscopy. \u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003ePublications that used associated reagents: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e: Shen et al. Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=26712908\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eBlood. 2016. March 17: 127(11): 1449-58\u003c\/a\u003e.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eCell Morphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_CL046_large.png?11951554244795478865\" alt=\"\" width=\"410\" height=\"308\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLuciferase assay\u003c\/strong\u003e: 10\u003csup\u003e4\u003c\/sup\u003e-10\u003csup\u003e6\u003c\/sup\u003e cells were placed in wells of a 96-well plate and 0.3 mg of d-luciferin was added to the indicated wells. The plate was immediately imaged using Perkin Elmer IVIS® Spectrum system.\u003c\/p\u003e\n\u003cp\u003e \u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Xenogen_for_website_CL046_large.png?9589520428399380534\" alt=\"\" width=\"360\" height=\"162\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFlow cytometry\u003c\/strong\u003e of CT26.WT-Fluc-Neo\/eGFP-Puro (green) and control (grey) cells.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/FACS_CL-IM28_-Layout_large.jpg?17868159506229327795\" alt=\"\" width=\"320\" height=\"314\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBioluminescent images showing growth of a subcutaneous CT26.WT-Fluc tumor in an athymic mouse\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/CL043_IM70_Web_large.png?v=1460738256\" alt=\"\" width=\"307\" height=\"263\"\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch5\u003e10\u003csup\u003e7\u003c\/sup\u003e CT26.WT-Fluc-Neo cells (\u003ca href=\"https:\/\/www.imanislife.com\/products\/cl043\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eImanis Life catalog #CL043\u003c\/a\u003e) were injected subcutaneously into the right flanks of female NCR athymic mice. Mice were imaged at day 0 on the day of cell implantation and subsequently at days 7 and 11 using a Perkin Elmer IVIS® Spectrum system, at 10-15 minutes post intraperitoneal injection of D-luciferin at 150 mg\/kg. Tumor size was measured using calipers. Data from a representative mouse (ID#5815) is shown.\u003c\/h5\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15990785441864,"sku":"CL046-STAN","price":2100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL046.png?v=1467242850"},{"product_id":"cl052","title":"B16F10-Fluc-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Melanoma\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMelanoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Firefly luciferase (Fluc) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 1ug\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eB16F10-Fluc-Puro is a polyclonal population of the murine melanoma cell line B16F10 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-6475.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC\u003csup\u003e®\u003c\/sup\u003e CRL-6475\u003csup\u003e™\u003c\/sup\u003e)\u003c\/a\u003e transduced with \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv012\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-Fluc-P2A-Puro (LV012)\u003c\/a\u003e encoding the firefly luciferase (Fluc) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the puromycin resistance gene (Puro) via a P2A cleavage peptide.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003e\u003cspan\u003eThe parental B16F10 cell line was authenticated and are certified free of interspecies cross-contamination \u003c\/span\u003eby short tandem repeat (STR) profiling with 27 STR loci. \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high Fluc expressing cell line suitable for use as a positive control cell line in bioluminescence assays to verify luciferase expression in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: B16F10 cells can form subcutaneous tumors after flank implantation or metastases in the lungs of mice after intravenous administration. The \u003cem\u003ein vivo\u003c\/em\u003e growth of these metastases can be monitored using bioluminescent imaging with D-luciferin substrate.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_CL052_01173966-b5e1-4aeb-913c-cb4a6512fb41_large.png?10449878875895410690\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLuciferase Assay: \u003c\/strong\u003e10\u003csup\u003e4\u003c\/sup\u003e, 10\u003csup\u003e5\u003c\/sup\u003e, or 10\u003csup\u003e6\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003ecells were placed in wells of a 96-well plate and 0.3 mg of d-luciferin was added to the indicated wells. The plate was immediately imaged using a Xenogen IVIS Spectrum.\u003c\/p\u003e\n\u003cp style=\"padding-left: 30px;\"\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Xenogen_photo_for_website_large.png?10449878875895410690\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBioluminescent images showing growth of a subcutaneous B16-Fluc tumor in an athymic mouse. \u003c\/strong\u003e\u003c\/p\u003e\n\u003ch5 style=\"padding-left: 60px;\"\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/B16_Fluc_Puro_6383_5e7-5e8_large.png?v=1459265348\" alt=\"\" style=\"float: left;\" width=\"303\" height=\"288\"\u003e\u003c\/h5\u003e\n\u003ch5\u003e\u003c\/h5\u003e\n\u003ch5\u003e\u003c\/h5\u003e\n\u003ch5\u003e\u003c\/h5\u003e\n\u003ch5\u003e\u003c\/h5\u003e\n\u003ch5\u003e\u003c\/h5\u003e\n\u003ch5\u003e\u003c\/h5\u003e\n\u003ch5\u003e\u003c\/h5\u003e\n\u003ch5\u003e\u003c\/h5\u003e\n\u003ch5\u003e\u003c\/h5\u003e\n\u003ch5\u003e\u003c\/h5\u003e\n\u003ch5\u003e\u003c\/h5\u003e\n\u003ch5\u003e\u003c\/h5\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch5\u003e10\u003csup\u003e7\u003c\/sup\u003e B16-Fluc-Puro cells were injected subcutaneously into the right flanks of female NCR athymic mice. Mice were imaged at day 0 on the day of cell implantation and at day 7 using a Perkin Elmer IVIS® Spectrum system, at 10-15 minutes post intraperitoneal injection of D-luciferin at 150 mg\/kg. Tumor size was measured using calipers. Data from a representative mouse (ID#6383) is shown.\u003c\/h5\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15985385734216,"sku":"CL052-STAN","price":1500.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/B16_Fluc_Puro_6383_5e7-5e8.png?v=1466608547"},{"product_id":"cl068","title":"B16F10-Fluc-Neo\/eGFP-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Melanoma\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMelanoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Firefly luciferase (Fluc) with neomycin resistance (Neo) for selection with G418 and enhanced green fluorescent protein (eGFP) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 0.8mg\/mL G418, 1 ug\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eB16F10-Fluc-Neo\/eGFP-Puro is a polyclonal population of the murine melanoma cell line B16F10 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-6475.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC\u003csup\u003e®\u003c\/sup\u003e CRL-6475\u003csup\u003e™\u003c\/sup\u003e)\u003c\/a\u003e transduced with 1) \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv011\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-Fluc-P2A-Neo (LV011)\u003c\/a\u003e encoding the firefly luciferase (Fluc) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene (Neo) via a P2A cleavage peptide and 2) \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e encoding enhanced green fluorescent protein (eGFP) cDNA under the SFFV promoter and the puromycin resistance gene (Puro) under control of the PGK promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eThe parental B16F10 cell line was authenticated and are certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 27 STR loci.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high Fluc\/eGFP expressing cell line suitable for use as a positive control cell line in bioluminescence assays and fluorescence assays to verify Fluc or GFP expression respectively in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: B16F10 cells form metastases in the lungs of mice. The in vivo growth of these metastases can be monitored using bioluminescent imaging with D-luciferin substrate or optical imaging for GFP fluorescence.\u003c\/p\u003e\n\u003cp\u003eNote: In-life imaging for GFP fluorescence is not recommended due to high background autofluorescence. Tissues may be harvested post mortem for analysis by conventional microscopy.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications that used associated reagents: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e: Shen et al. Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=26712908\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eBlood. 2016. March 17: 127(11): 1449-58\u003c\/a\u003e. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_CL068_large.png?7369768470837093808\" alt=\"\" width=\"425\" height=\"320\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFlow Cytometry for eGFP: \u003c\/strong\u003eB16F10-Fluc-Neo\/eGFP-Puro (green) or control (B16-Fluc-Neo; grey) cells were fixed with paraformaldehyde and analyzed by flow cytometry (20,000 events). \u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/FACs_for_COA_d3b6cfb5-4580-4218-93d8-dde4986dcbf7_large.jpg?17687294685366761459\" alt=\"\" width=\"314\" height=\"305\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLuciferase Assay: \u003c\/strong\u003e10\u003csup\u003e4\u003c\/sup\u003e, 10\u003csup\u003e5\u003c\/sup\u003e, or 10\u003csup\u003e6\u003c\/sup\u003e\u003cspan\u003e cells were placed in wells of a 96-well plate and 0.3 mg of d-luciferin was added to the indicated wells. The plate was immediately imaged using a Xenogen IVIS Spectrum.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp style=\"padding-left: 30px;\"\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Xenogen_for_website_CL068_large.png?1182789705958990134\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBioluminescent images showing growth of a subcutaneous B16F10-Fluc tumor in an athymic mouse\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp style=\"padding-left: 60px;\"\u003e\u003cstrong\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/B16_Fluc_Puro_6383_5e7-5e8_large.png?v=1459265348\" alt=\"\" width=\"301\" height=\"286\"\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch5\u003e10\u003csup\u003e7\u003c\/sup\u003e B16-Fluc-Puro cells (\u003ca href=\"https:\/\/www.imanislife.com\/products\/cl052\"\u003eImanis Life catalog#CL052\u003c\/a\u003e) were injected subcutaneously into the right flanks of female NCR athymic mice. Mice were imaged at day 0 on the day of cell implantation and at day 7 using a Perkin Elmer IVIS® Spectrum system, at 10-15 minutes post intraperitoneal injection of D-luciferin at 150 mg\/kg. Tumor size was measured using calipers. Data from a representative mouse (ID#6383) is shown.\u003c\/h5\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15985337663560,"sku":"CL068-STAN","price":2100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL068.png?v=1467242817"},{"product_id":"cl069","title":"B16F10-Fluc-Neo\/mNIS-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Melanoma\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMelanoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Firefly luciferase (Fluc) with neomycin resistance (Neo) for selection with G418 and murine sodium iodide symporter (mNIS) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 0.8mg\/mL G418, 1 µg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eB16F10-Fluc-Neo\/mNIS-Puro is a polyclonal population of the murine melanoma cell line B16F10 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-6475.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC\u003csup\u003e®\u003c\/sup\u003e CRL-6475\u003csup\u003e™\u003c\/sup\u003e)\u003c\/a\u003e transduced with 1) \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv011\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-Fluc-P2A-Neo (LV011)\u003c\/a\u003e encoding the firefly luciferase (Fluc) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene (Neo) via a P2A cleavage peptide and 2) \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv022\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-mNIS-PGK-Puro (LV022)\u003c\/a\u003e encoding the murine sodium iodide symporter (mNIS) cDNA under the SFFV promoter and the puromycin resistance gene (Puro) under control of the PGK promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eThe parental B16F10 cell line was authenticated and are certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 27 STR loci.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high Fluc\/mNIS expressing cell line suitable for use as a positive control cell line in bioluminescence assays and iodine uptake assays to verify luciferase or NIS expression respectively in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: B16F10 cells form metastases in the lungs of mice. The in vivo growth of these metastases can be monitored using noninvasive, high-resolution 3D PET\/SPECT imaging with the \u003ca href=\"https:\/\/www.imanislife.com\/pages\/what-is-nis\" title=\"What is NIS?\"\u003eNIS reporter gene\u003c\/a\u003e or bioluminescent imaging with D-luciferin substrate.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_CL069_large.png?8101728750907998841\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLuciferase Assay: \u003c\/strong\u003e10\u003csup\u003e4\u003c\/sup\u003e, 10\u003csup\u003e5\u003c\/sup\u003e, or 10\u003csup\u003e6\u003c\/sup\u003e\u003cspan\u003e cells were placed in wells of a 96-well plate and 0.3 mg of d-luciferin was added to the indicated wells. The plate was immediately imaged using a Xenogen IVIS Spectrum.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp style=\"padding-left: 30px;\"\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Xenogen_for_website_CL069_large.png?18063140096320584084\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNIS Function Assay\u003c\/strong\u003e (Iodine Uptake): Cells were incubated with I-125 for 1h in the presence or absence of KClO4, an inhibitor of NIS-mediated iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter.\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Uptake_for_COA_IM63_large.jpg?8824693468658471088\" alt=\"\" style=\"line-height: 1.4;\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBioluminescent images showing growth of a subcutaneous B16F10-Fluc tumor in an athymic mouse\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp style=\"padding-left: 60px;\"\u003e\u003cstrong\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/B16_Fluc_Puro_6383_5e7-5e8_large.png?v=1459265348\" alt=\"\" width=\"301\" height=\"286\"\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch5\u003e10\u003csup\u003e7\u003c\/sup\u003e B16-Fluc-Puro cells (\u003ca href=\"https:\/\/www.imanislife.com\/products\/cl052\"\u003eImanis Life catalog#CL052\u003c\/a\u003e) were injected subcutaneously into the right flanks of female NCR athymic mice. Mice were imaged at day 0 on the day of cell implantation and at day 7 using a Perkin Elmer IVIS® Spectrum system, at 10-15 minutes post intraperitoneal injection of D-luciferin at 150 mg\/kg. Tumor size was measured using calipers. Data from a representative mouse (ID#6383) is shown.\u003c\/h5\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15985363157064,"sku":"CL069-STAN","price":2100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL069.png?v=1467242826"},{"product_id":"cl057","title":"B16F10-mNIS-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Melanoma\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMelanoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Murine sodium iodide symporter (mNIS) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 1μg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eB16F10-mNIS-Puro is a polyclonal population of the murine melanoma cell line B16F10 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-6475.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC\u003csup\u003e®\u003c\/sup\u003e CRL-6475\u003csup\u003e™\u003c\/sup\u003e)\u003c\/a\u003e transduced with \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv022\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-mNIS-PGK-Puro (LV022)\u003c\/a\u003e encoding the murine sodium iodide symporter (mNIS) cDNA under the SFFV promoter and the puromycin resistance gene (Puro) under control of the PGK promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eAuthentication of the parental B16F10 cell line was performed by short tandem repeat (STR) profiling with 27 STR loci. STR profiling of B16F10 cells are verified and there is no interspecies cross contamination detected.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high mNIS expressing cell line suitable for use as a positive control cell line in iodine uptake assays to verify NIS expression in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: B16F10 cells form metastases in the lungs of mice. The in vivo growth of these metastases can be monitored using noninvasive, high-resolution 3D PET\/SPECT imaging.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_CL057_large.png?6522828604680932499\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgene Validation:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eNIS Function Assay (Iodine Uptake):\u003c\/strong\u003e\u003cspan\u003e Cells were incubated with \u003c\/span\u003e\u003csup\u003e125\u003c\/sup\u003e\u003cspan\u003eI for 1h in the presence or absence of KClO\u003c\/span\u003e\u003csub\u003e4\u003c\/sub\u003e\u003cspan\u003e, an inhibitor of iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter. \u003c\/span\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Uptake_for_COA_IM64_large.jpg?2381453620196967661\" alt=\"\" style=\"line-height: 1.4;\"\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15985453269064,"sku":"CL057-STAN","price":1500.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL057.png?v=1467242838"},{"product_id":"cl067","title":"B16F10-mNIS-Neo\/eGFP-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Melanoma\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMelanoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Murine sodium iodide symporter (mNIS) with neomycin resistance (Neo) for selection with G418 and enhanced green fluorescent protein (eGFP) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 0.8mg\/mL G418, 1 µg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eB16F10-mNIS-Neo\/eGFP-Puro is a polyclonal population of the murine melanoma cell line B16F10 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-6475.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC\u003csup\u003e®\u003c\/sup\u003e CRL-6475\u003csup\u003e™\u003c\/sup\u003e)\u003c\/a\u003e transduced with 1) \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv025\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-mNIS-P2A-Neo (LV025)\u003c\/a\u003e encoding the murine sodium iodide symporter (mNIS) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene (Neo) via a P2A cleavage peptide and 2) \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e encoding enhanced green fluorescent protein (eGFP) cDNA under the SFFV promoter and the puromycin resistance gene (Puro) under control of the PGK promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eAuthentication of the parental B16F10 cell line was performed by short tandem repeat (STR) profiling with 27 STR loci. STR profiling of B16F10 cells are verified and there is no interspecies cross contamination detected.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high mNIS\/eGFP expressing cell line suitable for use as a positive control cell line in iodine uptake assays and fluorescence assays to verify NIS or GFP expression respectively in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: B16F10 cells form metastases in the lungs of mice. The in vivo growth of these metastases can be monitored using noninvasive, high-resolution 3D PET\/SPECT imaging or optical imaging for GFP fluorescence.\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003eNote\u003c\/span\u003e: In-life imaging for GFP fluorescence is not recommended due to high background autofluorescence. Tissues may be harvested post mortem for analysis by conventional microscopy.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications that used associated reagents: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e: Shen et al. Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=26712908\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eBlood. 2016. March 17: 127(11): 1449-58\u003c\/a\u003e. \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_CL067_large.png?14038378322321441216\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNIS Function Assay\u003c\/strong\u003e (Iodine Uptake): Cells were incubated with I-125 for 1h in the presence or absence of KClO4, an inhibitor of NIS-mediated iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Uptake_for_COA_IM60_large.jpg?10851516886770637212\" alt=\"\"\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFlow Cytometry for eGFP: \u003c\/strong\u003eB16F10-mNIS-Neo\/eGFP-Puro (green) or control cells (grey) were fixed with paraformaldehyde and analyzed by flow cytometry (20,000 events). \u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/FACs_for_COA_203de14d-04a9-4970-80d3-f206f66c3fe0_large.jpg?16739302515273220406\" alt=\"\"\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15985442324552,"sku":"CL067-STAN","price":2100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL067.png?v=1467242836"},{"product_id":"cl025","title":"4T1-mNIS-Neo\/eGFP-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Line\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Breast-Cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMammary carcinoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Murine sodium iodide symporter (mNIS) with neomycin resistance (Neo) for selection with G418 and enhanced green fluorescent protein (eGFP) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e RPMI, 10% FBS, 1% Pen\/Strep, 0.1 mg\/mL G418, \u003cspan\u003e2\u003c\/span\u003e\u003cspan\u003e μg\/mL puromycin\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003e4T1-mNIS-Neo\/eGFP-Puro is a polyclonal population of the murine mammary carcinoma cell line \u003cspan\u003e4T1 \u003c\/span\u003e\u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-2539.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CRL-2539™)\u003c\/a\u003e\u003cspan\u003e transduced\u003c\/span\u003e with 1) \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv025\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-mNIS-P2A-Neo (LV025)\u003c\/a\u003e encoding murine sodium iodide symporter (mNIS) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene via P2A sequence, and 2) \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031) \u003c\/a\u003eencoding enhanced green fluorescent protein (eGFP) cDNA under the spleen focus-forming virus (SFFV) promoter and the puromycin resistance gene under control of the PGK promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vectors used are self-inactivating (SIN) vectors in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication:\u003c\/strong\u003e The parental 4T1 cell line was authenticated and certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 27 STR loci.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high mNIS\/eGFP expressing cell line suitable for use as a positive control cell line in iodine uptake and fluorescence assays to verify NIS or GFP expression respectively in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: 4T1 cells form tumors post implantation into immunocompromised or syngenic Balb\/c mice. The in vivo growth of these tumors can be monitored using noninvasive, high-resolution 3D PET\/SPECT imaging or optical imaging for GFP fluorescence.\u003c\/p\u003e\n\u003cp\u003eNote: In-life imaging for GFP fluorescence is not recommended due to high background autofluorescence. Tissues may be harvested post mortem for analysis by conventional microscopy.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications that used associated reagents: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e: Shen et al. Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=26712908\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eBlood. 2016. March 17: 127(11): 1449-58\u003c\/a\u003e. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e \u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_COA_CL025_large.png?10441033642872396673\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgene Validation:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNIS function: NIS mediated I-125 uptake assay in the presence or absence of KClO4, a competitive inhibitor of iodine uptake.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Uptake_for_COA_IM57_large.jpg?14054758222794282362\" alt=\"\" width=\"447\" height=\"274\"\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFlow Cytometry for eGFP: \u003c\/strong\u003e4T1-mNIS-Neo\/eGFP-Puro (green) or control (4T1-mNIS-Puro; grey) cells were fixed with paraformaldehyde and analyzed by flow cytometry (20,000 events).\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Flow_for_COA_189df904-e3f6-4ea0-a641-7fe0ff6b65a1_large.jpg?11093421565195537269\" alt=\"\"\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15981643628616,"sku":"CL025-STAN","price":2100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_COA_CL025.png?v=1467242796"},{"product_id":"cl065","title":"4T1-mNIS-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Line\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Breast-Cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMammary carcinoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Murine sodium iodide symporter (mNIS) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e RPMI, 10% FBS, 1% Pen\/Strep, \u003cspan\u003e2\u003c\/span\u003e\u003cspan\u003e μg\/mL puromycin\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003e4T1-mNIS-Neo\/eGFP-Puro is a polyclonal population of the murine mammary carcinoma cell line\u003cspan\u003e 4T1 \u003c\/span\u003e\u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-2539.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CRL-2539™)\u003c\/a\u003e\u003cspan\u003e transduced\u003c\/span\u003e with \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv022\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-mNIS-PGK-Puro (LV022)\u003c\/a\u003e encoding murine sodium iodide symporter (mNIS) cDNA under the spleen focus-forming virus (SFFV) promoter and the puromycin resistance gene (Puro) under control of the PGK promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eThe parental 4T1 cell line was authenticated and cells are certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 27 STR loci.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high mNIS expressing cell line suitable for use as a positive control cell line in iodine uptake and fluorescence assays to verify NIS expression in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: 4T1 cells form tumors post implantation into mice. The in vivo growth of these tumors can be monitored using noninvasive, high-resolution 3D PET\/SPECT imaging.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_CL065_large.png?1013688038983764119\" alt=\"\"\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgene Validation:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNIS function: NIS mediated iodine uptake assay in the presence or absence of KClO4, a competitive inhibitor of uptake.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Uptake_for_COA_IM56_large.jpg?16901504764337026850\" alt=\"\"\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15981655752776,"sku":"CL065-STAN","price":1500.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL065.png?v=1467242803"},{"product_id":"cl066","title":"4T1-mNIS-Puro\/Fluc-Neo","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Line\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Breast-Cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMammary carcinoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Murine sodium iodide symporter (mNIS) with puromycin resistance (Puro) for selection with puromycin and firefly luciferase (Fluc) with neomycin resistance (Neo) for selection with G418\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e RPMI, 10% FBS, 1% Pen\/Strep, 0.1 mg\/mL G418, \u003cspan\u003e2\u003c\/span\u003e\u003cspan\u003e μg\/mL puromycin\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription:\u003c\/strong\u003e 4T1-mNIS-Puro\/Fluc-Neo is a polyclonal population of the murine mammary carcinoma cell line 4T1 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-2539.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CRL-2539™)\u003c\/a\u003e transduced with 1) \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv022\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-mNIS-PGK-Puro (LV022)\u003c\/a\u003e encoding murine sodium iodide symporter (mNIS) cDNA under the spleen focus-forming virus (SFFV) promoter and the puromycin resistance gene (Puro) under control of the PGK promoter, and 2) \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv011\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-Fluc-P2A-Neo (LV011)\u003c\/a\u003e encoding the firefly luciferase (Fluc) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene (Neo) via a P2A sequence. \u003c\/p\u003e\n\u003cp\u003eThe lentiviral vectors used are self-inactivating (SIN) vectors in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998). \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eThe parental 4T1 cell line was authenticated and cells are certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 27 STR loci.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high mNIS\/Fluc expressing cell line suitable for use as a positive control cell line in iodine uptake and bioluminescence assays to verify NIS or luciferase expression respectively in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: 4T1 cells form tumors post implantation in mice. The in vivo growth of these tumors can be monitored using noninvasive, high-resolution 3D PET\/SPECT imaging or bioluminescent imaging with D-luciferin substrate.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_CL066_large.png?9507322756890588412\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgene Validation:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNIS function\u003c\/strong\u003e: NIS mediated iodine uptake assay in the presence or absence of KClO4, a competitive inhibitor of uptake.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Uptake_for_COA_IM59_large.jpg?7349015937276936778\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLuciferase Assay: \u003c\/strong\u003e10\u003csup\u003e4\u003c\/sup\u003e, 10\u003csup\u003e5\u003c\/sup\u003e, or 10\u003csup\u003e6\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003ecells were placed in wells of a 96-well plate and 0.3 mg of d-luciferin was added to the indicated wells. The plate was immediately imaged using a Xenogen IVIS Spectrum.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Xenogen_for_website_CL066_large.png?15300639277451873428\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBioluminescent images of a subcutaneous 4T1-Fluc-Neo tumor in an athymic mouse. \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp style=\"text-align: left;\"\u003e\u003cspan\u003e10\u003c\/span\u003e\u003csup\u003e7\u003c\/sup\u003e\u003cspan\u003e 4T1-Fluc-Neo cells (\u003c\/span\u003e\u003ca href=\"https:\/\/www.imanislife.com\/products\/cl020-1\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eImanis Life catalog #CL020\u003c\/a\u003e\u003cspan\u003e) were\u003c\/span\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/4T1-Fluc-Neo_3876_IM114_large.png?v=1459803103\" alt=\"\" width=\"278\" height=\"308\" style=\"float: right;\"\u003e\u003cspan\u003e injected subcutaneously into the right flanks of female NCR athymic mice. Mice were imaged at day 0 on the day of cell implantation and at day 16 using a Perkin Elmer IVIS® Spectrum system, at 10-15 minutes post intraperitoneal injection of D-luciferin at 150 mg\/kg. Tumor size was measured using calipers. Data from a representative mouse (ID#3876) is shown.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15981471367240,"sku":"CL066-STAN","price":2100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL066.png?v=1467242802"},{"product_id":"cl016","title":"RG2-hNIS","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e Rat\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e Glial tumor\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgene:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/pages\/what-is-nis\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman sodium iodide symporter (hNIS)\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription:\u003c\/strong\u003e RG2-hNIS is a polyclonal population of the rat glial tumor RG2 cell line transduced with \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv001\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-hNIS (LV001)\u003c\/a\u003e encoding the human sodium iodide symporter (hNIS) cDNA under the spleen focus-forming virus (SFFV) promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high hNIS expressing clone suitable for use as a positive control cell line in I-125 uptake assays to validate NIS expression in your lentiviral transduced cells. \u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: This rat glial tumor cell line grows as a glioma after intracranial injection into Fisher 344 rats. Once large it’s growth can be monitored noninvasively using high-resolution 3D SPECT or PET imaging due to disruption of the blood-brain-barrier allowing for radioiodine access to the tumor cells.\u003c\/p\u003e\n\u003cp\u003eNote: disrupting the blood-brain barrier with mannitol treatment may allow for NIS imaging at early stages of tumor formation. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Cell_Photos_for_COA_CL016_large.jpg?6798270302640773195\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNIS Function Assay (Iodine Uptake):\u003c\/strong\u003e Cells were incubated with \u003csup\u003e125\u003c\/sup\u003eI for 1h in the presence or absence of KClO\u003csub\u003e4\u003c\/sub\u003e, an inhibitor of iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/I125_uptake_for_COA_CL016_large.jpg?11585960446810577198\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15996325265480,"sku":"CL016-STAN","price":1500.0,"currency_code":"USD","in_stock":true}]},{"product_id":"cl053","title":"B16F10-eGFP-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Melanoma\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMelanoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Enhanced green fluorescent protein (eGFP) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 1ug\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eB16F10-eGFP-Puro is a polyclonal population of the murine melanoma cell line B16F10 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-6475.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC\u003csup\u003e®\u003c\/sup\u003e CRL-6475\u003csup\u003e™\u003c\/sup\u003e)\u003c\/a\u003e transduced with \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e encoding enhanced green fluorescent protein (eGFP) cDNA under the spleen focus-forming virus (SFFV) promoter and the puromycin resistance gene (Puro) under control of the PGK promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eThe parental B16F10 cell line was authenticated and are certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 27 STR loci.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high eGFP expressing cell line suitable for use as a positive control cell line in fluorescence assays to verify GFP expression in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: B16F10 cells form metastases in the lungs of mice. The in vivo growth of these metastases can be monitored using optical imaging for GFP fluorescence.\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003eNote\u003c\/span\u003e: In-life imaging for GFP fluorescence is not recommended due to high background autofluorescence. Tissues may be harvested post mortem for analysis by conventional fluorescence microscopy. For in vivo imaging, please use luciferase or the nonimmunogenic murine\u003ca href=\"https:\/\/www.imanislife.com\/pages\/what-is-nis\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e NIS reporter gene\u003c\/a\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_CL053_large.png?10031320188232842505\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgene Validation:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFlow Cytometry for eGFP: \u003c\/strong\u003eB16F10-GFP-Puro (green) and control B16F10 (grey) cells were fixed with paraformaldehyde and analyzed by flow cytometry (20,000 events).\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/FACs_for_COA_large.jpg?1081379216963855122\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications that used associated reagents: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e: Shen et al. Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=26712908\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eBlood. 2016. March 17: 127(11): 1449-58\u003c\/a\u003e. \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15985403461704,"sku":"CL053-STAN","price":1500.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL053.png?v=1467242813"},{"product_id":"cl045","title":"CT26.WT-mNIS-Neo\/eGFP-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Colorectal-Cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eColorectal Cancer\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Murine sodium iodide symporter (mNIS) with neomycin resistance (Neo) for selection with G418 and enhanced green fluorescent protein (eGFP) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 0.4mg\/mL G418, 3μg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eCT26.WT-mNIS-Neo\/eGFP-Puro is a polyclonal population of the murine colorectal carcinoma cell line CT26.WT \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-2638.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CRL-2638™)\u003c\/a\u003e transduced with 1) \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv025\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-mNIS-P2A-Neo (LV025)\u003c\/a\u003e encoding the murine sodium iodide symporter (mNIS) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene (Neo) via a P2A cleavage peptide and 2) \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e encoding enhanced green fluorescent protein (eGFP) cDNA under the spleen focus-forming virus (SFFV) promoter and the puromycin resistance gene (Puro) under control of the PGK promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eAuthentication of the parental CT26.WT cell line was performed by short tandem repeat (STR) profiling with 27 STR loci. STR profiling of CT26.WT cells are verified and there is no interspecies cross contamination detected.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high mNIS\/eGFP expressing cell line suitable for use as a positive control cell line in iodine uptake assays and fluorescence assays to verify NIS or GFP expression respectively in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: CT26.WT cells form tumors post implantation into syngenic Balb\/c mice. The in vivo growth of these metastases can be monitored using noninvasive, high-resolution 3D PET\/SPECT imaging or optical imaging for GFP fluorescence.\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003eNote\u003c\/span\u003e: In-life imaging for GFP fluorescence is not recommended due to high background autofluorescence. Tissues may be harvested post mortem for analysis by conventional microscopy. For in vivo imaging, please use the nonimmunogenic murine\u003ca href=\"https:\/\/www.imanislife.com\/pages\/what-is-nis\"\u003e\u003cspan\u003e \u003c\/span\u003eNIS reporter gene\u003c\/a\u003e or firefly luciferase.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_CL045_large.png?3114288663300171953\" alt=\"\" width=\"415\" height=\"311\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNIS Function Assay (Iodine Uptake):\u003c\/strong\u003e Cells were incubated with \u003csup\u003e125\u003c\/sup\u003eI for 1h in the presence or absence of KClO\u003csub\u003e4\u003c\/sub\u003e, an inhibitor of iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter.\u003c\/p\u003e\n\u003cp\u003e \u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Uptake_for_COA_IM50_large.jpg?17712648668605391670\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e \u003cstrong\u003eFlow cytometry\u003c\/strong\u003e of CT26.WT-mNIS-Neo\/GFP-Puro (green) and control (gray) cells.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Flow_for_COA_b94d4a31-7711-400e-95c8-beb352cc4548_large.jpg?966990999080616647\" alt=\"\" width=\"300\" height=\"287\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications that used associated reagents: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e: Shen et al. Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=26712908\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eBlood. 2016. March 17: 127(11): 1449-58\u003c\/a\u003e. \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15990802219080,"sku":"CL045-STAN","price":2100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL045.png?v=1467242855"},{"product_id":"cl047","title":"CT26.WT-mNIS-Neo\/Fluc-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Colorectal-Cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eColorectal Cancer\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Murine \u003ca href=\"https:\/\/www.imanislife.com\/pages\/what-is-nis\" target=\"_blank\" rel=\"noopener noreferrer\"\u003esodium iodide symporter\u003c\/a\u003e (mNIS) with neomycin resistance (Neo) for selection with G418 and firefly luciferase (Fluc) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 0.4mg\/mL G418, 3μg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eCT26.WT-mNIS-Neo\/Fluc-Puro is a polyclonal population of the murine colorectal carcinoma cell line CT26.WT \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-2638.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CRL-2638™)\u003c\/a\u003e transduced with 1) \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv025\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-mNIS-P2A-Neo (LV025)\u003c\/a\u003e encoding the murine sodium iodide symporter (mNIS) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene (Neo) via a P2A cleavage peptide and 2) \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv012\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-Fluc-P2A-Puro (LV012)\u003c\/a\u003e encoding firefly luciferase (Fluc) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the puromycin resistance gene (Puro) via a P2A cleavage peptide.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eAuthentication of the parental CT26.WT cell line was performed by short tandem repeat (STR) profiling with 27 STR loci. STR profiling of CT26.WT cells are verified and there is no interspecies cross contamination detected.\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high mNIS\/Fluc expressing cell line suitable for use as a positive control cell line in iodine uptake assays and bioluminescence assays to verify NIS or luciferase expression respectively in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: CT26.WT cells form tumors post implantation into immunocompromised or syngenic Balb\/c mice. The in vivo growth of these metastases can be monitored using noninvasive, high-resolution 3D PET\/SPECT imaging or bioluminescent imaging with D-luciferin substrate.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_CL047_large.png?5212891781446043886\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNIS Function Assay (Iodine Uptake):\u003c\/strong\u003e Cells were incubated with \u003csup\u003e125\u003c\/sup\u003eI for 1h in the presence or absence of KClO\u003csub\u003e4\u003c\/sub\u003e, an inhibitor of iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Uptake_for_COA_IM49_large.jpg?14156749894722234345\" alt=\"\" width=\"447\" height=\"272\"\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLuciferase Assay: \u003c\/strong\u003e10\u003csup\u003e4\u003c\/sup\u003e, 10\u003csup\u003e5\u003c\/sup\u003e, or 10\u003csup\u003e6\u003c\/sup\u003e cells were placed in wells of a 96-well plate and 0.3 mg of d-luciferin was added to the indicated wells. The plate was immediately imaged using a Xenogen IVIS Spectrum.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Xenogen_for_website_CL047_large.png?18068783332443165765\" alt=\"\" width=\"440\" height=\"154\"\u003e\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eBioluminescent images showing growth of a subcutaneous CT26.WT-Fluc tumor in an athymic mouse\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/CL043_IM70_Web_large.png?v=1460738256\" alt=\"\" width=\"352\" height=\"302\"\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch5\u003e10\u003csup\u003e7\u003c\/sup\u003e CT26.WT-Fluc-Neo cells (\u003ca href=\"https:\/\/www.imanislife.com\/products\/cl043\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eImanis Life catalog #CL043\u003c\/a\u003e) were injected subcutaneously into the right flanks of female NCR athymic mice. Mice were imaged at day 0 on the day of cell implantation and subsequently at days 7 and 11 using a Perkin Elmer IVIS® Spectrum system, at 10-15 minutes post intraperitoneal injection of D-luciferin at 150 mg\/kg. Tumor size was measured using calipers. Data from a representative mouse (ID#5815) is shown.\u003c\/h5\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15990792454216,"sku":"CL047-STAN","price":2100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL047.png?v=1467242854"},{"product_id":"cl061","title":"CT26.WT-mNIS-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Colorectal-Cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eColorectal Cancer\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e \u003cspan\u003eMurine \u003c\/span\u003e\u003ca href=\"https:\/\/www.imanislife.com\/pages\/what-is-nis\" target=\"_blank\" rel=\"noopener noreferrer\"\u003esodium iodide symporter\u003c\/a\u003e\u003cspan\u003e (mNIS) with \u003c\/span\u003epuromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 3µg\/mL  puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eCT26.WT-mNIS-Puro is a polyclonal population of the murine colorectal carcinoma cell line CT26.WT \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-2638.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CRL-2638™)\u003c\/a\u003e transduced with \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv022\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-mNIS-PGK-Puro (LV022)\u003c\/a\u003e encoding the murine sodium iodide symporter (mNIS) cDNA under the spleen focus-forming virus (SFFV) promoter and the puromycin resistance gene (Puro) under control of the PGK promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eThe parental CT26.WT cell line was authenticated and certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 27 STR loci.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high mNIS expressing cell line suitable for use as a positive control cell line in iodine uptake assays to verify NIS in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: CT26.WT-mNIS cells form tumors post implantation into syngenic Balb\/c mice. The in vivo growth of these metastases can be monitored using noninvasive, high-resolution 3D PET or SPECT imaging.\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL061_large.png?v=1459641562\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNIS Function Assay (Iodine Uptake):\u003c\/strong\u003e Cells were incubated with \u003csup\u003e125\u003c\/sup\u003eI for 1h in the presence or absence of KClO\u003csub\u003e4\u003c\/sub\u003e, an inhibitor of iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter.\u003c\/p\u003e\n\u003cp\u003e \u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/CL061_Iodine_uptake_large.png?v=1459641609\" alt=\"\"\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15990805037128,"sku":"CL061-STAN","price":1500.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL061.png?v=1466608504"},{"product_id":"cl063","title":"HCT116-eGFP-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.imanislife.com\/collections\/cell-lines\/Human-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/colorectal-cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eColorectal carcinoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Enhanced green fluorescent protein (eGFP) with puromycin resistance for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 1μg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eHCT116-eGFP-Puro is a polyclonal population of the human colorectal carcinoma cell line HCT116 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CCL-247.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CCL-247™)\u003c\/a\u003e transduced with \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e encoding enhanced green fluorescent protein (eGFP) cDNA under the SFFV promoter and the puromycin resistance gene (Puro) under the PGK promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMycoplasma Testing: \u003c\/strong\u003eThis cell line has been tested for mycoplasma contamination and is certified mycoplasma free.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eAuthentication of the parental HCT116 cell line was performed by short tandem repeat (STR) profiling with 9 STR loci including CSF1PO, D13S317, D16S539, D5S818, D7S820, TH01, TPOX, vWA and sex chromosome marker \u003cem\u003eAmelogenin\u003c\/em\u003e. STR profiling of HCT116 cells are verified and there is no interspecies cross contamination detected.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high eGFP expressing clone suitable for use as a positive control cell line in fluorescence assays to validate GFP expression in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: This human colorectal cell line grows as xenografts in immunocompromised mice.  \u003cspan style=\"text-decoration: underline;\"\u003eNote\u003c\/span\u003e: In life optical imaging GFP fluorescence is not recommended due to high background autofluorescence. Tissues may be harvested post mortem for analysis by conventional microscopy. \u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003eFor in vivo imaging, please use the human\u003ca href=\"https:\/\/www.imanislife.com\/pages\/what-is-nis\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e NIS reporter gene\u003c\/a\u003e for high resolution 3D imaging.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e﻿﻿\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Pics_for_website_CL063_large.png?9701448709664420127\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgene Validation:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFlow cytometry of HCT116-eGFP-Puro for GFP expression (green) versus control (gray) cells.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/FACs_for_COA_IM53_large.jpg?12649889027116695546\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003ePublications that used associated reagents: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e: Shen et al. Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=26712908\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eBlood. 2016. March 17: 127(11): 1449-58\u003c\/a\u003e.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15996282372168,"sku":"CL063-STAN","price":1500.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Pics_for_website_CL063.png?v=1467242859"},{"product_id":"cl028","title":"HCT116-hNIS-Neo\/eGFP-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Human-Line\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/colorectal-cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eColorectal carcinoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/pages\/what-is-nis\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman sodium iodide symporter (hNIS)\u003c\/a\u003e with neomycin resistance (Neo) for selection with G418 and enhanced green fluorescent protein (eGFP) with puromycin resistance for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 0.5 mg\/mL G418, 1μg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eHCT116-hNIS-Neo\/eGFP-Puro is a polyclonal population of the human colorectal carcinoma cell line HCT116 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CCL-247.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CCL-247™)\u003c\/a\u003e transduced with 1) \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv013\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-hNIS-Neo (LV013)\u003c\/a\u003e encoding the human sodium iodide symporter (hNIS) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene (Neo) via an IRES and 2) \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e encoding enhanced green fluorescent protein (eGFP) cDNA under the SFFV promoter and the puromycin resistance gene (Puro) under the PGK promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMycoplasma Testing: \u003c\/strong\u003eThis cell line has been tested for mycoplasma contamination and is certified mycoplasma free.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eAuthentication of the parental HCT116 cell line was performed by short tandem repeat (STR) profiling with 9 STR loci including CSF1PO, D13S317, D16S539, D5S818, D7S820, TH01, TPOX, vWA and sex chromosome marker \u003cem\u003eAmelogenin\u003c\/em\u003e. STR profiling of HCT116 cells are verified and there is no interspecies cross contamination detected.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high hNIS\/eGFP expressing clone suitable for use as a positive control cell line in iodine uptake assays and fluorescence assays to validate NIS or GFP expression respectively in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: This human colorectal cell line grows as xenografts in immunocompromised mice. Growth of these tumors can be monitored using noninvasive high-resolution 3D SPECT or PET imaging or optical imaging for GFP fluorescence.\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003eNote\u003c\/span\u003e: In life optical imaging GFP fluorescence is not recommended due to high background autofluorescence. Tissues may be harvested post mortem for analysis by conventional microscopy. \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_CL028_large.png?16853555925974865408\" alt=\"\" width=\"457\" height=\"344\"\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNIS Function Assay (Iodine Uptake):\u003c\/strong\u003e Cells were incubated with \u003csup\u003e125\u003c\/sup\u003eI for 1h in the presence or absence of KClO\u003csub\u003e4\u003c\/sub\u003e, an inhibitor of iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter\u003c\/p\u003e\n\u003cp\u003e \u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Uptake_for_COA_IM51_large.jpg?1776230826629005500\" alt=\"\" width=\"449\" height=\"273\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFlow Cytometry for GFP: \u003c\/strong\u003eHCT116-hNIS-Neo\/eGFP-Puro (green) and control (gray) cells were fixed with paraformaldehyde and analyzed by flow cytometry (20,000 events).\u003c\/p\u003e\n\u003cp style=\"padding-left: 30px;\"\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/FACs_for_COA_IM51_large.jpg?5767101162325753933\" alt=\"\" width=\"300\" height=\"283\"\u003e\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003ePublications that used associated reagents: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e: Shen et al. Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=26712908\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eBlood. 2016. March 17: 127(11): 1449-58\u003c\/a\u003e. \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15996283027528,"sku":"CL028-STAN","price":2100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL028.png?v=1467242873"},{"product_id":"cl070","title":"HCT116-Fluc-Neo\/eGFP-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Human-Line\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/colorectal-cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eColorectal carcinoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Firefly luciferase (Fluc) with neomycin resistance (Neo) for selection with G418 and enhanced green fluorescent protein (eGFP) with puromycin resistance for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 0.5 mg\/mL G418, 1 μg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eHCT116-Fluc-Neo\/eGFP-Puro is a polyclonal population of the human colorectal carcinoma cell line HCT116 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CCL-247.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CCL-247™)\u003c\/a\u003e transduced with \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv011\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-Fluc-P2A-Neo (LV011)\u003c\/a\u003e encoding firefly luciferase (Fluc) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene (Neo) via a P2A cleavage peptide and \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e encoding enhanced green fluorescent protein (eGFP) cDNA under the SFFV promoter and the puromycin resistance gene (Puro) under the PGK promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMycoplasma Testing: \u003c\/strong\u003eThis cell line has been tested for mycoplasma contamination and is certified mycoplasma free.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eAuthentication of the parental HCT116 cell line was performed by short tandem repeat (STR) profiling with 9 STR loci including CSF1PO, D13S317, D16S539, D5S818, D7S820, TH01, TPOX, vWA and sex chromosome marker \u003cem\u003eAmelogenin\u003c\/em\u003e. STR profiling of HCT116 cells are verified and there is no interspecies cross contamination detected.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high Fluc\/eGFP expressing cell line suitable for use as a positive control cell line in bioluminescence assays and fluorescence assays to verify luciferase or GFP expression respectively in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: This human colorectal cell line grows as xenografts in immunocompromised mice. Growth of these tumors can be monitored \u003cem\u003ein vivo\u003c\/em\u003e using noninvasive bioluminescent imaging with D-luciferin substrate or optical imaging for GFP fluorescence. \u003cspan style=\"text-decoration: underline;\"\u003eNote\u003c\/span\u003e: In life optical imaging GFP fluorescence is not recommended due to high background autofluorescence. Tissues may be harvested post mortem for analysis by conventional microscopy.\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003ePublications that used associated reagents: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e: Shen et al. Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=26712908\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eBlood. 2016. March 17: 127(11): 1449-58\u003c\/a\u003e.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_CL070_large.png?5060583989808742392\" alt=\"\" width=\"409\" height=\"307\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFlow cytometry:\u003c\/strong\u003e Histograms showing GFP expression in HCT116-Fluc-Neo\/eGFP-Puro (green) versus control HCT-Fluc-Neo cells (gray)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/FACs_for_COA_IM65_large.jpg?16389545338728611126\" alt=\"\" width=\"321\" height=\"311\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLuciferase Assay: \u003c\/strong\u003e10\u003csup\u003e4\u003c\/sup\u003e, 10\u003csup\u003e5\u003c\/sup\u003e, or 10\u003csup\u003e6\u003c\/sup\u003e cells were placed in wells of a 96-well plate and 0.3 mg of d-luciferin was added to the indicated wells. The plate was immediately imaged using a Xenogen IVIS Spectrum.\u003c\/p\u003e\n\u003cp style=\"padding-left: 30px;\"\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Xenogen_for_website_CL070_large.png?6659209132395926850\" alt=\"\" width=\"439\" height=\"151\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBioluminescent images of a subcutaneous HCT116-Fluc-Puro tumor in an athymic mouse\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/CL008_4772_Web_image_HCT116_large.png?v=1460939560\" alt=\"\" width=\"360\" height=\"280\"\u003e\u003c\/p\u003e\n\u003ch5\u003e10\u003csup\u003e7\u003c\/sup\u003e HCT116-Fluc-Puro cells (\u003ca href=\"https:\/\/www.imanislife.com\/products\/cl008\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eImanis Life catalog #CL008\u003c\/a\u003e) were injected subcutaneously into the right flanks of female NCR athymic mice. Mice were imaged at day 0 on the day of cell implantation and at days 7 and 16 using a Perkin Elmer IVIS® Spectrum system, at 10-15 minutes post intraperitoneal injection of D-luciferin at 150 mg\/kg. Tumor size was measured using calipers. Data from a representative mouse (ID#4772) is shown.\u003c\/h5\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15990810312776,"sku":"CL070-STAN","price":2100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL070.png?v=1467242861"},{"product_id":"cl054","title":"LL\/2-mNIS-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Lines\" target=\"_blank\" title=\"mouse cancer cell lines expressing reporter genes for multimodality in vivo imaging using SPECT PET bioluminescence fluorescence\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Lung-Cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLewis Lung Carcinoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Murine \u003ca href=\"https:\/\/www.imanislife.com\/pages\/what-is-nis\" target=\"_blank\" title=\"NIS reporter gene sodium iodide symporter high resolution 3D in vivo imaging\" rel=\"noopener noreferrer\"\u003esodium iodide symporter\u003c\/a\u003e (mNIS) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 2μg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eLL\/2-mNIS-Puro is a polyclonal population of the Lewis lung carcinoma cell line LL\/2 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-1642.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CRL-1642™)\u003c\/a\u003e, \u003cspan\u003ealso commonly known as LLC1,\u003c\/span\u003e transduced with \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv022\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-mNIS-PGK-Puro (LV022)\u003c\/a\u003e encoding the murine sodium iodide symporter (mNIS) cDNA under the spleen focus-forming virus (SFFV) promoter and the puromycin resistance gene (Puro) under control of the PGK promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eThe parental LL\/2 cell line was authenticated and certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 27 STR loci.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high mNIS expressing cell line suitable for use as a positive control cell line in iodine uptake assays to verify NIS in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: LL\/2 cells form tumors post implantation into immunocompromised or syngeneic C57BL\/6 mice. The in vivo growth of these metastases can be monitored using noninvasive, high-resolution 3D PET\/SPECT imaging.\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47\u003c\/span\u003e\u003c\/a\u003e.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_CL054_large.png?10225962069141873550\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNIS Function Assay (Iodine Uptake):\u003c\/strong\u003e Cells were incubated with \u003csup\u003e125\u003c\/sup\u003eI for 1h in the presence or absence of KClO\u003csub\u003e4\u003c\/sub\u003e, an inhibitor of iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Uptake_for_COA_IM38_large.jpg?3609170499058005828\" alt=\"\" style=\"line-height: 1.4;\"\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15996299575368,"sku":"CL054-STAN","price":1500.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL054.png?v=1467242894"},{"product_id":"cl050","title":"LL\/2-Fluc-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Lung-Cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLewis Lung Carcinoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Firefly luciferase (Fluc) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 2μg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eLL\/2-Fluc-Puro is a polyclonal population of the Lewis lung carcinoma cell line LL\/2 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-1642.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CRL-1642™)\u003c\/a\u003e, \u003cspan\u003ealso commonly known as LLC1, \u003c\/span\u003etransduced with \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv012\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-Fluc-P2A-Puro (LV012)\u003c\/a\u003e encoding the firefly luciferase (Fluc) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the puromycin resistance gene (Puro) via a P2A cleavage peptide.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eThe parental LL\/2 cell line was authenticated and certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 27 STR loci.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high Fluc expressing cell line suitable for use as a positive control cell line in bioluminescence assays to verify luciferase expression in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: LL\/2 cells form tumors post implantation into mice. The in vivo growth of primary tumors or metastases can be monitored using bioluminescent imaging with D-luciferin substrate.\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003eNOTE\u003c\/span\u003e: LL\/2-Fluc tumors may be grown in C57BL\/6 immunocompetent mice but host immune selection against the immunogenic firefly luciferase protein may occur, resulting in selection and growth of clones with lower or poor luciferase expression.\u003c\/p\u003e\n\u003cp\u003eFor in vivo imaging in immunocompetent hosts, please use the nonimmunogenic murine\u003ca href=\"https:\/\/www.imanislife.com\/pages\/what-is-nis\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e NIS reporter gene\u003c\/a\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_CL050_large.png?6364288225822972124\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLuciferase Assay: \u003c\/strong\u003e10\u003csup\u003e4\u003c\/sup\u003e, 10\u003csup\u003e5\u003c\/sup\u003e, or 10\u003csup\u003e6\u003c\/sup\u003e cells were placed in wells of a 96-well plate and 0.3 mg of d-luciferin was added to the indicated wells. The plate was immediately imaged using a Xenogen IVIS Spectrum.\u003c\/p\u003e\n\u003cp style=\"padding-left: 30px;\"\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Xenogen_for_website_CL050_large.png?941747765681474527\" alt=\"\" width=\"442\" height=\"150\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBioluminescent images of a subcutaneous LL\/2-Fluc-Puro tumor in an athymic mouse\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp style=\"text-align: left; padding-left: 30px;\"\u003e\u003cspan\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/LL2_Fluc_SQ_6867_large.png?v=1459117302\" alt=\"\" width=\"324\" height=\"381\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch5 style=\"text-align: left;\"\u003e\n\u003cspan\u003e1e7\u003cspan\u003e \u003c\/span\u003e \u003c\/span\u003eLL\/2-Fluc-Puro cells were injected subcutaneously into the right flanks of female NCR athymic mice. Mice were imaged at day 0 on the day of cell implantation and at day 7 using a Perkin Elmer IVIS® Spectrum system, at 10-15 minutes post intraperitoneal injection of D-luciferin at 150 mg\/kg. Tumor size was measured using calipers. Data from a representative mouse (ID#6867) is shown.\u003c\/h5\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15996297740360,"sku":"CL050-STAN","price":1500.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/LL2_Fluc_SQ_6867.png?v=1466613231"},{"product_id":"cl051","title":"LL\/2-eGFP-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Lines\" target=\"_blank\" title=\"Mouse cancer cell lines expressing reporter genes\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Lung-Cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLewis Lung Carcinoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Enhanced green fluorescent protein (eGFP) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong style=\"line-height: 1.4;\"\u003eMedia:\u003c\/strong\u003e\u003cspan style=\"line-height: 1.4;\"\u003e DMEM, 10% FBS, 1% Pen\/Strep, 2 μg\/mL puromycin\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eLL\/2-eGFP-Puro is a polyclonal population of the Lewis lung carcinoma cell line LL\/2 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-1642.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CRL-1642™)\u003c\/a\u003e, \u003cspan\u003ealso commonly known as LLC1, \u003c\/span\u003etransduced with \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e encoding enhanced green fluorescent protein (eGFP) cDNA under the spleen focus-forming virus (SFFV) promoter and the puromycin resistance gene (Puro) under control of the PGK promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication:  \u003c\/strong\u003eThe parental LL\/2 cell line was authenticated and certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 27 STR loci.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high eGFP expressing cell line suitable for use as a positive control cell line in fluorescence assays to verify GFP expression in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: LL\/2 cells form tumors post implantation into syngeneic C57BL mice. In vivo imaging for GFP fluorescence is not recommended due to high background autofluorescence. Tissues may be harvested post mortem for analysis by conventional microscopy.\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003eFor in vivo imaging, please use the nonimmunogenic murine\u003ca href=\"https:\/\/www.imanislife.com\/pages\/what-is-nis\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e NIS reporter gene\u003c\/a\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_CL051_large.png?5079256044768415936\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFlow Cytometry for eGFP: \u003c\/strong\u003eLL\/2-eGFP-Puro cells (green) or control (LL\/2, grey) cells were fixed with paraformaldehyde and analyzed by flow cytometry (20,000 events).\u003c\/p\u003e\n\u003cp style=\"padding-left: 30px;\"\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/FACS_for_COA_IM35_large.jpg?5534018665086900642\" alt=\"\" style=\"line-height: 1.4;\"\u003e\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003ePublications that used associated reagents: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e: Shen et al. Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=26712908\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eBlood. 2016. March 17: 127(11): 1449-58\u003c\/a\u003e. \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15996297969736,"sku":"CL051-STAN","price":1500.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL051.png?v=1467242883"},{"product_id":"cl023","title":"4T1-Fluc-Neo\/eGFP-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Line\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Breast-Cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMammary carcinoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Firefly luciferase (Fluc) with neomycin resistance (Neo) for selection with G418 and enhanced green fluorescent protein (eGFP) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e RPMI, 10% FBS, 1% Pen\/Strep, 0.1 mg\/mL G418, 2 \u003cspan\u003eμ\u003c\/span\u003eg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003e4T1-Fluc-Neo\/eGFP-Puro is a polyclonal population of the murine mammary carcinoma cell line 4T1 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-2539.aspx\"\u003e(ATCC® CRL-2539™)\u003c\/a\u003e transduced with  1) \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv011\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-Fluc-Neo (LV011)\u003c\/a\u003e encoding firefly luciferase (Fluc) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene via P2A sequence, and 2) \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e encoding enhanced green fluorescent protein (eGFP) cDNA under the spleen focus-forming virus (SFFV) promoter and the puromycin resistance gene under control of the PGK promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vectors used are self-inactivating (SIN) vectors in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMycoplasma Testing: \u003c\/strong\u003eThe 4T1-Fluc-Neo\/eGFP-Puro cell line has been tested for mycoplasma contamination and is certified mycoplasma free.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eThe parental 4T1 cell line was authenticated and certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 27 STR loci.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high luciferase\/GFP expressing cell line suitable for use as a positive control cell line in bioluminescence and fluorescence assays to verify luciferase or GFP expression respectively in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: 4T1 cells form tumors post implantation into syngenic Balb\/c mice. The in vivo growth of these tumors can be monitored using noninvasive bioluminescent imaging or optical imaging for GFP fluorescence.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications using associated reagents:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e: Shen et al. Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia. \u003c\/span\u003e\u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=26712908\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eBlood. 2016. March 17: 127(11): 1449-58\u003c\/a\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eCell Morphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e \u003cimg alt=\"Microscopy shows normal 4T1 morphology in 4T1-Fluc-Neo\/eGFP-Puro cells, high GFP expression\" src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_COA_CL023_large.png?12533684957448921018\" width=\"347\" height=\"261\"\u003e\u003c\/p\u003e\n\u003cp\u003e \u003cstrong\u003eLuciferase Assay: \u003c\/strong\u003e10\u003csup\u003e4\u003c\/sup\u003e, 10\u003csup\u003e5\u003c\/sup\u003e, or 10\u003csup\u003e6\u003c\/sup\u003e cells were placed in wells of a 96-well plate and 0.3 mg of d-luciferin was added to the indicated wells. The plate was immediately imaged using a Xenogen IVIS Spectrum.\u003c\/p\u003e\n\u003cp style=\"text-align: left;\"\u003e\u003cimg alt=\"Xenogen imaging with D-luciferin substrate shows high luciferase expression in 4T1-Fluc-Neo\/eGFP-Puro cells\" src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Xenogen_for_website_CL023_large.png?6713866618548886276\" style=\"float: none;\" width=\"420\" height=\"154\"\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cstrong\u003eFlow Cytometry for eGFP: \u003c\/strong\u003e\u003c\/strong\u003e4T1-Fluc-Neo\/eGFP-Puro (green) or control (4T1-mNIS-Puro; grey) cells were fixed with paraformaldehyde and analyzed by flow cytometry (20,000 events).\u003c\/p\u003e\n\u003cp style=\"text-align: left;\"\u003e\u003cimg alt=\"Flow cytometry shows high GFP expression in 4T1-Fluc-Neo\/eGFP-Puro cells\" src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Flow_for_COA_large.jpg?9453109034538658041\" style=\"float: none; margin-left: -0.5px;\" width=\"331\" height=\"320\"\u003e\u003c\/p\u003e\n\u003cp style=\"text-align: left;\"\u003e\u003cstrong\u003eBioluminescent images of a subcutaneous 4T1-Fluc-Neo tumor in an athymic mouse. \u003c\/strong\u003e\u003c\/p\u003e\n10\u003csup\u003e7\u003c\/sup\u003e 4T1-Fluc-Neo cells (\u003ca href=\"https:\/\/www.imanislife.com\/products\/cl020-1\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eImanis Life catalog #CL020\u003c\/a\u003e) were\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/4T1-Fluc-Neo_3876_IM114_large.png?v=1459803103\" alt=\"\" width=\"278\" height=\"308\" style=\"float: right;\"\u003e injected subcutaneously into the right flanks of female NCR athymic mice. Mice were imaged at day 0 on the day of cell implantation and at day 16 using a Perkin Elmer IVIS® Spectrum system, at 10-15 minutes post intraperitoneal injection of D-luciferin at 150 mg\/kg. Tumor size was measured using calipers. Data from a representative mouse (ID#3876) is shown.\n\u003cp style=\"text-align: left;\"\u003e \u003c\/p\u003e\n\u003ch5\u003e\u003c\/h5\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":11597487491,"sku":"CL023-STAN","price":2100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_COA_CL023.png?v=1467242792"},{"product_id":"cl071","title":"LL\/2-mNIS-Neo\/eGFP-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Lines\" target=\"_blank\" title=\"mouse cancer cell lines expressing reporter genes multimodality imaging\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Lung-Cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLewis Lung Carcinoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Murine \u003ca href=\"https:\/\/www.imanislife.com\/pages\/what-is-nis\" target=\"_blank\" title=\"NIS reporter gene sodium iodide symporter high resolution 3D in vivo imaging\" rel=\"noopener noreferrer\"\u003esodium iodide symporter\u003c\/a\u003e (mNIS) with neomycin resistance (Neo) for selection with G418 and enhanced green fluorescent protein (eGFP) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 1.25mg\/mL G418, 2μg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eLL\/2-mNIS-Neo\/eGFP-Puro is a polyclonal population of the Lewis lung carcinoma cell line LL\/2 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-1642.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CRL-1642™)\u003c\/a\u003e, \u003cspan\u003ealso commonly known as LLC1, \u003c\/span\u003etransduced with \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv025\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-mNIS-P2A-Neo (LV025)\u003c\/a\u003e encoding the murine sodium iodide symporter (mNIS) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene (Neo) via a P2A cleavage peptide and \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e encoding enhanced green fluorescent protein (eGFP) cDNA under the spleen focus-forming virus (SFFV) promoter and the puromycin resistance gene (Puro) under control of the PGK promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vectors used are self-inactivating (SIN) vectors in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong style=\"line-height: 1.4;\"\u003eCell Line Authentication: \u003c\/strong\u003eThe parental LL\/2 cell line was authenticated and certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 27 STR loci.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high mNIS\/eGFP expressing cell line suitable for use as a positive control cell line in iodine uptake and fluorescence assays to verify NIS or GFP expression respectively in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: LL\/2 cells form tumors post implantation into immunocompromised or syngenic C57BL\/6 mice. The in vivo growth of these metastases can be monitored using non-invasive, high-resolution 3D PET\/SPECT imaging with radioiodine. In vivo imaging for GFP fluorescence is not recommended due to high background autofluorescence. Tissues may be harvested post mortem for analysis by conventional microscopy.\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47\u003c\/span\u003e\u003c\/a\u003e.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_CL071_large.png?6668097721302217899\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNIS Function Assay (Iodine Uptake):\u003c\/strong\u003e Cells were incubated with \u003csup\u003e125\u003c\/sup\u003eI for 1h in the presence or absence of KClO\u003csub\u003e4\u003c\/sub\u003e, an inhibitor of iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Uptake_for_COA_IM66_large.jpg?7389160438820306140\" alt=\"\" style=\"line-height: 1.4;\" width=\"452\" height=\"277\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFlow Cytometry for eGFP: \u003c\/strong\u003eLL\/2-mNIS-Neo\/eGFP-Puro (green) or control (grey) cells were fixed with paraformaldehyde and analyzed by flow cytometry (20,000 events).\u003c\/p\u003e\n\u003cp style=\"padding-left: 30px;\"\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/FACs_for_COA_IM66_large.jpg?2301393492985112123\" alt=\"\" width=\"343\" height=\"323\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications that used associated reagents: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e: Shen et al. Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=26712908\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eBlood. 2016. March 17: 127(11): 1449-58\u003c\/a\u003e. \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15996299083848,"sku":"CL071-STAN","price":2100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL071.png?v=1467242892"},{"product_id":"cl073","title":"LL\/2-Fluc-Neo\/eGFP-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Lines\" target=\"_blank\" title=\"mouse cancer cell lines reporter genes\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Lung-Cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLewis Lung Carcinoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Firefly luciferase (Fluc) with neomycin resistance (Neo) for selection with G418 and enhanced green fluorescent protein (eGFP) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong style=\"line-height: 1.4;\"\u003eMedia:\u003c\/strong\u003e\u003cspan style=\"line-height: 1.4;\"\u003e DMEM, 10% FBS, 1% Pen\/Strep, 1.25mg\/mL G418, 2μg\/mL puromycin\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eLL\/2-Fluc-Neo\/eGFP-Puro is a polyclonal population of the Lewis lung carcinoma cell line LL\/2 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-1642.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CRL-1642™)\u003c\/a\u003e, also commonly known as LLC1, transduced with \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv011\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-Fluc-P2A-Neo (LV011)\u003c\/a\u003e encoding the firefly luciferase (Fluc) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene (Neo) via a P2A cleavage peptide and \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e encoding enhanced green fluorescent protein (eGFP) cDNA under the spleen focus-forming virus (SFFV) promoter and the puromycin resistance gene (Puro) under control of the PGK promoter.\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"line-height: 1.4;\"\u003eThe lentiviral vectors used are self-inactivating (SIN) vectors in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003c\/span\u003e\u003cem style=\"line-height: 1.4;\"\u003ecis\u003c\/em\u003e\u003cspan style=\"line-height: 1.4;\"\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong style=\"line-height: 1.4;\"\u003eCell Line Authentication: \u003c\/strong\u003eThe parental LL\/2 cell line was authenticated and certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 27 STR loci.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high Fluc\/eGFP expressing cell line suitable for use as a positive control cell line in bioluminescence and fluorescence assays to verify luciferase and GFP expression respectively in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: LL\/2 cells form tumors post implantation into immunocompromised or syngeneic C57BL\/6 mice. The in vivo growth of these metastases can be monitored using non-invasive bioluminescent imaging with D-luciferin substrate. In vivo imaging for GFP fluorescence is not recommended due to high background autofluorescence. Tissues may be harvested post mortem for analysis by conventional microscopy.\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003eFor in vivo imaging in immunocompetent animals, please use the nonimmunogenic murine\u003ca href=\"https:\/\/www.imanislife.com\/pages\/what-is-nis\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e NIS reporter gene\u003c\/a\u003e. \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications that used associated reagents: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e: Shen et al. Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=26712908\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eBlood. 2016. March 17: 127(11): 1449-58\u003c\/a\u003e.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology\u003c\/strong\u003e: Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_CL073_large.png?4715637878530078953\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eFlow Cytometry for eGFP:\u003c\/strong\u003e LL\/2-Fluc-Neo\/eGFP-Puro (green) or control (grey) cells were fixed with paraformaldehyde and analyzed by flow cytometry (20,000 events).\u003c\/p\u003e\n\u003cp style=\"padding-left: 30px;\"\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/FACs_for_COA_IM68_large.jpg?15435650378749529989\" alt=\"\" width=\"325\" height=\"309\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLuciferase Assay: \u003c\/strong\u003e10\u003csup\u003e4\u003c\/sup\u003e, 10\u003csup\u003e5\u003c\/sup\u003e, or 10\u003csup\u003e6\u003c\/sup\u003e cells were placed in wells of a 96-well plate and 0.3 mg of d-luciferin was added to the indicated wells. The plate was immediately imaged using a Xenogen IVIS Spectrum.\u003c\/p\u003e\n\u003cp style=\"padding-left: 30px;\"\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Xenogen_for_website_CL073_large.png?16324779792085583607\" alt=\"\" style=\"line-height: 1.4;\" width=\"423\" height=\"149\"\u003e \u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eBioluminescent images of a subcutaneous LL\/2-Fluc-Puro tumor in an athymic mouse\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp style=\"text-align: left; padding-left: 30px;\"\u003e\u003cspan\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/LL2_Fluc_SQ_6867_large.png?v=1459117302\" alt=\"\" width=\"279\" height=\"328\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003ch5 style=\"text-align: left;\"\u003e\u003cspan\u003e\u003cspan\u003e1e7\u003cspan\u003e \u003c\/span\u003e \u003c\/span\u003eLL\/2-Fluc-Puro cells (\u003ca href=\"https:\/\/www.imanislife.com\/products\/cl050\" target=\"_blank\" title=\"LLC LL\/2 Fluc firefly luciferase high cell line for Xenogen IVIS Spectrum in vivo imaging\" rel=\"noopener noreferrer\"\u003eImanis Life catalog #CL050\u003c\/a\u003e) were injected subcutaneously into the right flanks of female NCR athymic mice. Mice were imaged at day 0 on the day of cell implantation and at day 7 using a Perkin Elmer IVIS® Spectrum system, at 10-15 minutes post intraperitoneal injection of D-luciferin at 150 mg\/kg. Tumor size was measured using calipers. Data from a representative mouse (ID#6867) is shown.\u003c\/span\u003e\u003c\/h5\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15996297576520,"sku":"CL073-STAN","price":2100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL073.png?v=1467242884"},{"product_id":"cl072","title":"LL\/2-mNIS-Neo\/Fluc-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Lines\" target=\"_blank\" title=\"mouse cancer cell lines expressing reporter genes under selection\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Lung-Cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLewis Lung Carcinoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Murine \u003ca href=\"https:\/\/www.imanislife.com\/pages\/what-is-nis\" target=\"_blank\" title=\"NIS reporter gene sodium iodide symporter high resolution 3D in vivo imaging\" rel=\"noopener noreferrer\"\u003esodium iodide symporter\u003c\/a\u003e (mNIS) with neomycin resistance (Neo) for selection with G418 and firefly luciferase (Fluc) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 1.25mg\/mL G418, 2μg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eLL\/2-mNIS-Neo\/Fluc-Puro is a polyclonal population of the Lewis lung carcinoma cell line LL\/2 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-1642.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CRL-1642™)\u003c\/a\u003e, \u003cspan\u003ealso commonly known as LLC1,\u003c\/span\u003e transduced with \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv025\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-mNIS-P2A-Neo (LV025)\u003c\/a\u003e encoding the murine sodium iodide symporter (mNIS) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene (Neo) via a P2A cleavage peptide and \u003ca href=\"http:\/\/www.imanislife.com\/products\/lv012\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-Fluc-P2A-Puro (LV012)\u003c\/a\u003e encoding firefly luciferase (Fluc) cDNA under the spleen focus-forming virus (SFFV) promoter linked to neomycin resistance (Neo) via a P2A cleavage peptide.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vectors used are self-inactivating (SIN) vectors in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong style=\"line-height: 1.4;\"\u003eCell Line Authentication: \u003c\/strong\u003eThe parental LL\/2 cell line was authenticated and certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 27 STR loci.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high mNIS\/Fluc expressing cell line suitable for use as a positive control cell line in iodine uptake and bioluminescence assays to verify NIS and luciferase expression respectively in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: LL\/2 cells form tumors post implantation into immunocompromised or syngeneic C57BL\/6 mice. The in vivo growth of these metastases can be monitored using non-invasive, high-resolution 3D PET\/SPECT imaging with radioiodine or noninvasive bioluminescent imaging with D-luciferin substrate.\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003eNOTE\u003c\/span\u003e: Host immune selection against the immunogenic firefly luciferase protein may occur in an immunocompetent host, resulting in selection and growth of clones with lower or poor luciferase expression. If that is a concern, please consider using a cell line that expresses mNIS, e.g. LL\/2-mNIS-Puro (\u003ca href=\"https:\/\/www.imanislife.com\/products\/cl054\" target=\"_blank\" title=\"LLC cell line expressing murine sodium iodide symporter mNIS nonimmunogenic reporter gene for in vivo imaging\" rel=\"noopener noreferrer\"\u003eImanis catalog #CL054\u003c\/a\u003e).\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_CL072_large.png?989090800090529109\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e \u003cstrong\u003eNIS Function Assay (Iodine Uptake):\u003c\/strong\u003e Cells were incubated with \u003csup\u003e125\u003c\/sup\u003eI for 1h in the presence or absence of KClO\u003csub\u003e4\u003c\/sub\u003e, an inhibitor of iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e \u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Uptake_for_COA_IM67_large.jpg?311398049350489146\" alt=\"\" width=\"436\" height=\"267\"\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLuciferase Assay: \u003c\/strong\u003e10\u003csup\u003e4\u003c\/sup\u003e, 10\u003csup\u003e5\u003c\/sup\u003e, or 10\u003csup\u003e6\u003c\/sup\u003e cells were placed in wells of a 96-well plate and 0.3 mg of d-luciferin was added to the indicated wells. The plate was immediately imaged using a Xenogen IVIS Spectrum.\u003c\/p\u003e\n\u003cp style=\"padding-left: 30px;\"\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Xenogen_for_website_CL072_large.png?14912666878808685773\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eBioluminescent images of a subcutaneous LL\/2-Fluc-Puro tumor in an athymic mouse\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp style=\"padding-left: 30px;\"\u003e\u003cspan\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/LL2_Fluc_SQ_6867_large.png?v=1459117302\" alt=\"\" width=\"279\" height=\"328\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch5\u003e\u003cspan\u003e\u003cspan\u003e1e7\u003cspan\u003e \u003c\/span\u003e \u003c\/span\u003eLL\/2-Fluc-Puro cells (\u003ca href=\"https:\/\/www.imanislife.com\/products\/cl050\" target=\"_blank\" title=\"LLC LL\/2 Fluc firefly luciferase high cell line for Xenogen IVIS Spectrum in vivo imaging\" rel=\"noopener noreferrer\"\u003eImanis Life catalog #CL050\u003c\/a\u003e) were injected subcutaneously into the right flanks of female NCR athymic mice. Mice were imaged at day 0 on the day of cell implantation and at day 7 using a Perkin Elmer IVIS® Spectrum system, at 10-15 minutes post intraperitoneal injection of D-luciferin at 150 mg\/kg. Tumor size was measured using calipers. Data from a representative mouse (ID#6867) is shown.\u003c\/span\u003e\u003c\/h5\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15996297805896,"sku":"CL072-STAN","price":2100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL072.png?v=1467242894"},{"product_id":"cl087","title":"A375-Fluc-Neo\/hNIS-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Human-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/melanoma\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMelanoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes: \u003c\/strong\u003eFirefly luciferase (Fluc) with neomycin resistance (Neo) for selection with G418 and \u003ca href=\"http:\/\/www.imanislife.com\/pages\/what-is-nis\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman sodium iodide symporter (hNIS)\u003c\/a\u003e with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 0.6 mg\/mL G418, 1 μg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eA375-Fluc-Neo\/hNIS-Puro is a polyclonal population of the human malignant melanoma cell line A375 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-1619.aspx\"\u003e(ATCC® CRL-1619™)\u003c\/a\u003e transduced with 1) \u003ca href=\"\/products\/lv011\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-Fluc-P2A-Neo (LV011)\u003c\/a\u003e encoding the firefly luciferase (Fluc) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene (Neo) via a P2A cleavage peptide and 2) \u003ca href=\"\/products\/lv019\"\u003eLV-hNIS-P2A-Puro (LV019)\u003c\/a\u003e encoding the human sodium iodide symporter (hNIS) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the puromycin resistance gene (Puro) via a P2A cleavage peptide.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMycoplasma Testing: \u003c\/strong\u003e\u003cspan style=\"line-height: 1.4;\"\u003eThe A375-Fluc-Neo\/hNIS-Puro cell line has been tested for mycoplasma contamination and is certified mycoplasma free.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eThe parental A375 cell line was authenticated are certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 9 STR loci including CSF1PO, D13S317, D16S539, D5S818, D7S820, TH01, TPOX, vWA and sex chromosome marker \u003cem\u003eAmelogenin\u003c\/em\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses: \u003c\/strong\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high hNIS\/Fluc expressing cell line suitable for use as a positive control cell line in iodine uptake assays and bioluminescence assays to validate NIS or luciferase expression respectively in your lentiviral transduced cells. \u003cem\u003eIn vivo\u003c\/em\u003e: A375 cells form tumors post implantation into immunosuppressed mice. The in vivo growth of these tumors can be monitored using noninvasive, high-resolution 3D PET\/SPECT imaging or bioluminescent imaging with D-luciferin substrate.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eCell photos:\u003c\/strong\u003e Low- and high-density cell morphology (200X)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_Website_CL087_large.png?v=1454604030\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e \u003cstrong\u003eNIS Functional Assay (Iodine Uptake):\u003c\/strong\u003e Cells were incubated with \u003csup\u003e125\u003c\/sup\u003e\u003cspan\u003eI \u003c\/span\u003efor 1h in the presence or absence of KClO\u003csub\u003e4\u003c\/sub\u003e\u003cspan\u003e, an inhibitor of NIS-mediated iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Uptake_for_COA_IM84_large.jpg?v=1454604038\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLuciferase Assay: \u003c\/strong\u003e\u003cspan\u003e10\u003c\/span\u003e\u003csup\u003e4\u003c\/sup\u003e\u003cspan\u003e, 10\u003c\/span\u003e\u003csup\u003e5\u003c\/sup\u003e\u003cspan\u003e, or 10\u003c\/span\u003e\u003csup\u003e6\u003c\/sup\u003e\u003cspan\u003e cells were placed in wells of a 96-well plate and 30 μg\/mL of d-luciferin was added to the indicated wells. The plate was immediately imaged using a Xenogen IVIS Spectrum.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Xenogen_for_Website_CL087_large.png?v=1454604052\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBioluminescent images showing growth of a subcutaneous A375-Fluc tumor in an athymic mouse\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/CL055_A375_IM39_1299_Web_large.png?v=1461444842\" alt=\"\" width=\"429\" height=\"346\"\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch5\u003e10\u003csup\u003e7\u003c\/sup\u003e A375-Fluc-Puro cells (\u003ca href=\"https:\/\/www.imanislife.com\/products\/cl055\" target=\"_blank\" title=\"A375 luciferase cell line\" rel=\"noopener noreferrer\"\u003eImanis Life catalog #CL055\u003c\/a\u003e) were injected subcutaneously into the right flanks of female NCR athymic mice. Mice were imaged at day 0 on the day of cell implantation and subsequently at days 7 and 16 using a Perkin Elmer IVIS® Spectrum system, at 10-15 minutes post intraperitoneal injection of D-luciferin at 150 mg\/kg. Tumor size was measured using calipers. Data from a representative mouse (ID#1299) is shown.\u003c\/h5\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15985064640584,"sku":"CL087-STAN","price":2100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_Website_CL087.png?v=1466612931"},{"product_id":"cl058","title":"A375-hNIS-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Human-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/melanoma\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMelanoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes: \u003c\/strong\u003e\u003ca href=\"http:\/\/www.imanislife.com\/pages\/what-is-nis\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman sodium iodide symporter (hNIS)\u003c\/a\u003e with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 1 μg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eA375-hNIS-Puro is a polyclonal population of the human malignant melanoma cell line A375 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-1619.aspx\"\u003e(ATCC® CRL-1619™)\u003c\/a\u003e transduced with \u003ca href=\"\/products\/lv019\"\u003eLV-hNIS-P2A-Puro (LV019)\u003c\/a\u003e encoding the human sodium iodide symporter (hNIS) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the puromycin resistance gene (Puro) via a P2A cleavage peptide.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMycoplasma Testing: \u003c\/strong\u003e\u003cspan style=\"line-height: 1.4;\"\u003eThe A375-hNIS-Puro cell line has been tested for mycoplasma contamination and is certified mycoplasma free.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003e\u003cspan\u003eThe parental A375 cell line was authenticated are certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 9 STR loci including CSF1PO, D13S317, D16S539, D5S818, D7S820, TH01, TPOX, vWA and sex chromosome marker \u003c\/span\u003e\u003cem\u003eAmelogenin\u003c\/em\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high hNIS expressing cell line suitable for use as a positive control cell line in iodine uptake assays to verify NIS expression.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: A375 cells form tumors post implantation into immunosuppressed mice. The in vivo growth of these tumors can be monitored using noninvasive, high-resolution 3D PET\/SPECT imaging.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eCell photos:\u003c\/strong\u003e Low- and high-density cell morphology (200X)\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_CL058_large.png?12475237779393777186\" alt=\"\"\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNIS Functional Assay (Iodine Uptake):\u003c\/strong\u003e\u003cspan\u003e Cells were incubated with \u003c\/span\u003e\u003csup\u003e125\u003c\/sup\u003e\u003cspan\u003eI \u003c\/span\u003e\u003cspan\u003efor 1h in the presence or absence of KClO\u003c\/span\u003e\u003csub\u003e4\u003c\/sub\u003e\u003cspan\u003e, an inhibitor of NIS-mediated iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Uptake_for_COA_IM42_large.jpg?18346628984577946497\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15985120804936,"sku":"CL058-STAN","price":1500.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL058.png?v=1467242806"},{"product_id":"cl056","title":"A375-eGFP-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Human-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/melanoma\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMelanoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes: \u003c\/strong\u003eEnhanced green fluorescent protein (eGFP) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong style=\"line-height: 1.4;\"\u003eMedia:\u003c\/strong\u003e\u003cspan style=\"line-height: 1.4;\"\u003e DMEM, 10% FBS, 1% Pen\/Strep, 1 μg\/mL puromycin\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eA375-eGFP-Puro is a polyclonal population of the human malignant melanoma cell line A375 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-1619.aspx\"\u003e(ATCC® CRL-1619™)\u003c\/a\u003e transduced with \u003ca href=\"\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e encoding the enhanced green fluorescent protein (eGFP) cDNA under the spleen focus-forming virus (SFFV) promoter and the puromycin resistance gene (Puro) under the mouse phosphoglycerate kinase (PGK) promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMycoplasma Testing: \u003c\/strong\u003e\u003cspan style=\"line-height: 1.4;\"\u003eThe A375-eGFP-Puro cell line has been tested for mycoplasma contamination and is certified mycoplasma free.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003e\u003cspan\u003eThe parental A375 cell line was authenticated are certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 9 STR loci including CSF1PO, D13S317, D16S539, D5S818, D7S820, TH01, TPOX, vWA and sex chromosome marker \u003c\/span\u003e\u003cem\u003eAmelogenin\u003c\/em\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses: \u003c\/strong\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high GFP expressing cell line suitable for use as a positive control cell line in fluorescence assays to verify GFP expression in your lentiviral transduced cells. \u003cem\u003eIn vivo\u003c\/em\u003e: A375 cells form tumors post implantation into immunosuppressed mice. \u003c\/p\u003e\n\u003cp\u003eNote: In-life imaging for GFP fluorescence is not recommended due to high background autofluorescence and low light penetration. Tissues may be harvested post mortem for analysis by conventional fluorescence microscopy. For in vivo imaging, please use luciferase or the nonimmunogenic NIS reporter gene.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200X)\u003c\/p\u003e\n\u003cp style=\"text-align: left;\"\u003e\u003cimg alt=\"\" src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Photos_for_website_CL056_large.png?14833152388671653671\" style=\"float: none;\"\u003e\u003c\/p\u003e\n\u003cp\u003e \u003cstrong\u003eFlow Cytometry for eGFP: \u003c\/strong\u003eA375-eGFP-Puro (green) or control (A375-Fluc-Puro; grey) cells were fixed with paraformaldehyde and analyzed by flow cytometry (20,000 events).\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/files\/Flow_for_COA_IM40_large.jpg?5086251732008486129\" alt=\"\" width=\"321\" height=\"311\" style=\"float: left;\"\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications that used associated reagents: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e: Shen et al. Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=26712908\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eBlood. 2016. March 17: 127(11): 1449-58\u003c\/a\u003e.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15841781776456,"sku":"CL056-STAN","price":1500.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL056.png?v=1466612889"},{"product_id":"cl055","title":"A375-Fluc-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Human-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/melanoma\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMelanoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes: \u003c\/strong\u003eFirefly luciferase (Fluc) with puromycin resistance (Puro) for selection with puromycin.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong style=\"line-height: 1.4;\"\u003eMedia:\u003c\/strong\u003e\u003cspan style=\"line-height: 1.4;\"\u003e DMEM, 10% FBS, 1% Pen\/Strep, 1 μg\/mL puromycin\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eA375-Fluc-Puro is a polyclonal population of the human malignant melanoma cell line A375 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-1619.aspx\"\u003e(ATCC® CRL-1619™)\u003c\/a\u003e transduced with \u003ca href=\"\/products\/lv012\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-Fluc-P2A-Puro (LV012)\u003c\/a\u003e encoding the firefly luciferase (Fluc) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the puromycin resistance gene (Puro) via a P2A cleavage peptide.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMycoplasma Testing: \u003c\/strong\u003e\u003cspan style=\"line-height: 1.4;\"\u003eThe A375-Fluc-Puro cell line has been tested for mycoplasma contamination and is certified mycoplasma free.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003e\u003cspan\u003eThe parental A375 cell line was authenticated are certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 9 STR loci including CSF1PO, D13S317, D16S539, D5S818, D7S820, TH01, TPOX, vWA and sex chromosome marker \u003c\/span\u003e\u003cem\u003eAmelogenin\u003c\/em\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses: \u003c\/strong\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high luciferase expressing cell line suitable for use as a positive control cell line in bioluminescence assays to verify luciferase expression in your lentiviral transduced cells. \u003cem\u003eIn vivo\u003c\/em\u003e: A375 cells form tumors post implantation into immunosuppressed mice. The in vivo growth of these tumors can be monitored using noninvasive bioluminescent imaging.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200X)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL055_large.png?v=1454519741\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLuciferase Assay: \u003c\/strong\u003e10\u003csup\u003e4\u003c\/sup\u003e, 10\u003csup\u003e5\u003c\/sup\u003e, or 10\u003csup\u003e6\u003c\/sup\u003e cells were placed in wells of a 96-well plate and 0.3 mg of d-luciferin was added to the indicated wells. The plate was immediately imaged using a Xenogen IVIS Spectrum.\u003c\/p\u003e\n\u003cp style=\"padding-left: 30px;\"\u003e \u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Xenogen_for_website_CL055_large.png?v=1454519747\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBioluminescent images showing growth of a subcutaneous A375-Fluc tumor in an athymic mouse\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/CL055_A375_IM39_1299_Web_large.png?v=1461444842\" alt=\"\" width=\"429\" height=\"346\"\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch5\u003e10\u003csup\u003e7\u003c\/sup\u003e A375-Fluc-Puro cells (\u003ca href=\"https:\/\/www.imanislife.com\/products\/cl055\" target=\"_blank\" title=\"A375 luciferase cell line\" rel=\"noopener noreferrer\"\u003eImanis Life catalog #CL055\u003c\/a\u003e) were injected subcutaneously into the right flanks of female NCR athymic mice. Mice were imaged at day 0 on the day of cell implantation and subsequently at days 7 and 16 using a Perkin Elmer IVIS® Spectrum system, at 10-15 minutes post intraperitoneal injection of D-luciferin at 150 mg\/kg. Tumor size was measured using calipers. Data from a representative mouse (ID#1299) is shown.\u003c\/h5\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15985085022280,"sku":"CL055-STAN","price":1500.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL055.png?v=1466612933"},{"product_id":"cl088","title":"A375-iRFP-Neo","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Human-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/melanoma\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMelanoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes: \u003c\/strong\u003eNear-infrared fluorescent protein (iRFP; excitation\/emission: 690\/713nm) with neomycin resistance (neo) for selection with G418\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 0.6 mg\/mL G418\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eA375-iRFP-Neo is a polyclonal population of the human malignant melanoma cell line A375 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-1619.aspx\"\u003e(ATCC® CRL-1619™)\u003c\/a\u003e transduced with \u003ca href=\"\/products\/lv033\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-iRFP-P2A-Neo (LV033)\u003c\/a\u003e encoding the near-infrared fluorescent protein (iRFP) cDNA under the spleen focus-forming virus (SFFV) promoter and the puromycin resistance gene (Puro) under the mouse phosphoglycerate kinase (PGK) promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMycoplasma Testing: \u003c\/strong\u003e\u003cspan style=\"line-height: 1.4;\"\u003eThe A375-iRFP-Neo cell line has been tested for mycoplasma contamination and is certified mycoplasma free.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003e\u003cspan\u003eThe parental A375 cell line was authenticated are certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 9 STR loci including CSF1PO, D13S317, D16S539, D5S818, D7S820, TH01, TPOX, vWA and sex chromosome marker \u003c\/span\u003e\u003cem\u003eAmelogenin\u003c\/em\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high iRFP expressing cell line suitable for use as a positive control cell line in fluorescence assays to verify iRFP expression in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: A375 cells form tumors post implantation into immunosuppressed mice. The in vivo growth of these tumors may be monitored using noninvasive optical imaging. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200X)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL088_large.png?v=1454520143\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFlow Cytometry for iRFP: \u003c\/strong\u003eA375-iRFP-Neo (red) or control (A375-Fluc-Puro; grey) cells were fixed with paraformaldehyde and analyzed by flow cytometry (20,000 events).\u003c\/p\u003e\n\u003cp\u003e \u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/FACs_for_COA_IM85_large.jpg?v=1454520150\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003eNote:\u003c\/span\u003e If high resolution nonivasive imaging in living animals is needed, NIS reporter gene is preferred for detection of metastases. \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15985135353928,"sku":"CL088-STAN","price":1500.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL088.png?v=1466612980"},{"product_id":"cl090","title":"A375-iRFP-Neo\/hNIS-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Human-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/melanoma\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMelanoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Near-infrared fluorescent protein (iRFP; excitation\/emission: 690\/713nm) with neomycin resistance (Neo) for selection with G418 and \u003ca href=\"http:\/\/www.imanislife.com\/pages\/what-is-nis\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman sodium iodide symporter (hNIS)\u003c\/a\u003e with puromycin resistance for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 0.6 mg\/mL G418, 1 μg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eA375-iRFP-Neo\/hNIS-Puro is a polyclonal population of the human malignant melanoma cell line A375 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-1619.aspx\"\u003e(ATCC® CRL-1619™)\u003c\/a\u003e transduced with 1) \u003ca href=\"\/products\/lv033\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-iRFP-P2A-Neo (LV033)\u003c\/a\u003e encoding the near-infrared fluorescent protein (iRFP) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene (Neo) via a P2A cleavage peptide and 2) \u003ca href=\"\/products\/lv019\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-hNIS-P2A-Puro (LV019)\u003c\/a\u003e encoding the human sodium iodide symporter (hNIS) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the puromycin resistance gene (Puro) via a P2A cleavage peptide.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMycoplasma Testing: \u003c\/strong\u003e\u003cspan style=\"line-height: 1.4;\"\u003eThe A375-iRFP-Neo\/hNIS-Puro cell line has been tested for mycoplasma contamination and is certified mycoplasma free.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eThe parental A375 cell line was authenticated and certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 9 STR loci including CSF1PO, D13S317, D16S539, D5S818, D7S820, TH01, TPOX, vWA and sex chromosome marker \u003cem\u003eAmelogenin\u003c\/em\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high hNIS\/iRFP expressing cell line suitable for use as a positive control cell line in iodine uptake and fluorescence assays to verify NIS or iRFP expression respectively in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: A375 cells form tumors post implantation into immunosuppressed mice. The in vivo growth of these tumors can be monitored using noninvasive, high-resolution 3D PET\/SPECT imaging or noninvasive optical imaging.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eCell photos:\u003c\/strong\u003e Low- and high-density cell morphology (200X)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL090_large.png?v=1454603475\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNIS Functional Assay (Iodine Uptake):\u003c\/strong\u003e Cells were incubated with \u003csup\u003e125\u003c\/sup\u003e\u003cspan\u003eI \u003c\/span\u003efor 1h in the presence or absence of KClO\u003csub\u003e4\u003c\/sub\u003e\u003cspan\u003e, an inhibitor of NIS-mediated iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Uptake_for_COA_IM87_large.jpg?v=1454603484\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFlow Cytometry for iRFP: \u003c\/strong\u003eA375-iRFP-Neo\/hNIS-Puro (red) or isotype control (A375-Fluc-Puro; grey) cells were fixed with paraformaldehyde and analyzed by flow cytometry (20,000 events).\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/FAC_for_COA_IM87_large.jpg?v=1454603490\" alt=\"\" width=\"327\" height=\"328\"\u003e\u003c\/p\u003e\n\u003ch4\u003e\u003c\/h4\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15985166123080,"sku":"CL090-STAN","price":2100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL090.png?v=1466613036"},{"product_id":"cl089","title":"A375-iRFP-Neo\/Fluc-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Human-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/melanoma\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMelanoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Near-infrared fluorescent protein (iRFP; excitation\/emission: 690\/713nm) with neomycin resistance (Neo) for selection with G418 and firefly luciferase (Fluc) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 0.6 mg\/mL G418, 1 μg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eA375-iRFP-Neo\/Fluc-Puro is a polyclonal population of the human malignant melanoma cell line A375 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-1619.aspx\"\u003e(ATCC® CRL-1619™)\u003c\/a\u003e transduced with \u003ca href=\"\/products\/lv033\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-iRFP-P2A-Neo (LV033)\u003c\/a\u003e encoding the near-infrared fluorescent protein (iRFP) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene (Neo) via a P2A cleavage peptide and \u003ca href=\"\/products\/lv012\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-Fluc-P2A-Puro (LV012)\u003c\/a\u003e encoding the firefly luciferase (Fluc) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the puromycin resistance gene (Puro) via a P2A cleavage peptide.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMycoplasma Testing: \u003c\/strong\u003e\u003cspan style=\"line-height: 1.4;\"\u003eThe A375-iRFP-Neo\/Fluc-Puro cell line has been tested for mycoplasma contamination and is certified mycoplasma free.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eThe parental A375 cell line was authenticated and certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 9 STR loci including CSF1PO, D13S317, D16S539, D5S818, D7S820, TH01, TPOX, vWA and sex chromosome marker \u003cem\u003eAmelogenin\u003c\/em\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high luciferase\/iRFP expressing cell line suitable for use as a positive control cell line in bioluminescence and fluorescence assays to verify luciferase or iRFP expression respectively in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: A375 cells form tumors post implantation into immunosuppressed mice. The in vivo growth of these tumors can be monitored using noninvasive bioluminescent imaging or optical imaging.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eCell photos:\u003c\/strong\u003e Low- and high-density cell morphology (200X)\u003c\/p\u003e\n\u003cp\u003e \u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL089_large.png?v=1454603864\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFlow Cytometry for iRFP: \u003c\/strong\u003eA375-iRFP-Neo\/Fluc-Puro (red) or control (A375-Fluc-Puro; grey) cells were fixed with paraformaldehyde and analyzed by flow cytometry (20,000 events).\u003c\/p\u003e\n\u003cp style=\"padding-left: 30px;\"\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/FACs_for_COA_IM86_large.jpg?v=1454603877\" alt=\"\" width=\"304\" height=\"302\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLuciferase Assay: \u003c\/strong\u003e10\u003csup\u003e4\u003c\/sup\u003e, 10\u003csup\u003e5\u003c\/sup\u003e, or 10\u003csup\u003e6\u003c\/sup\u003e cells were placed in wells of a 96-well plate and 0.3 mg of d-luciferin was added to the indicated wells. The plate was immediately imaged using a Xenogen IVIS Spectrum.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Xenogen_for_Website_CL089_large.png?v=1454603870\" alt=\"\" width=\"445\" height=\"153\"\u003e\u003c\/p\u003e\n\u003cp\u003e \u003cstrong\u003eBioluminescent images showing growth of a subcutaneous A375-Fluc tumor in an athymic mouse\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/CL055_A375_IM39_1299_Web_large.png?v=1461444842\" alt=\"\" width=\"429\" height=\"346\"\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch5\u003e10\u003csup\u003e7\u003c\/sup\u003e A375-Fluc-Puro cells (\u003ca href=\"https:\/\/www.imanislife.com\/products\/cl055\" target=\"_blank\" title=\"A375 luciferase cell line\" rel=\"noopener noreferrer\"\u003eImanis Life catalog #CL055\u003c\/a\u003e) were injected subcutaneously into the right flanks of female NCR athymic mice. Mice were imaged at day 0 on the day of cell implantation and subsequently at days 7 and 16 using a Perkin Elmer IVIS® Spectrum system, at 10-15 minutes post intraperitoneal injection of D-luciferin at 150 mg\/kg. Tumor size was measured using calipers. Data from a representative mouse (ID#1299) is shown.\u003c\/h5\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15985156522056,"sku":"CL089-STAN","price":1800.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL089.png?v=1466613014"},{"product_id":"cl085","title":"A375-Fluc-Neo\/eGFP-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Human-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/melanoma\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMelanoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes: \u003c\/strong\u003eFirefly luciferase (Fluc) with neomycin resistance (Neo) for selection with G418 and enhanced green fluorescent protein (eGFP) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 0.6 mg\/mL G418, 1 μg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eA375-Fluc-Neo\/eGFP-Puro is a polyclonal population of the human malignant melanoma cell line A375 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-1619.aspx\"\u003e(ATCC® CRL-1619™)\u003c\/a\u003e transduced with \u003ca href=\"\/products\/lv011\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-Fluc-P2A-Neo (LV011)\u003c\/a\u003e encoding the firefly luciferase (Fluc) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene (Neo) via a P2A cleavage peptide and \u003ca href=\"\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e encoding the enhanced green fluorescent protein (eGFP) cDNA under the spleen focus-forming virus (SFFV) promoter and the puromycin resistance gene (Puro) under the mouse phosphoglycerate kinase (PGK) promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMycoplasma Testing: \u003c\/strong\u003e\u003cspan style=\"line-height: 1.4;\"\u003eThe A375-Fluc-Neo\/eGFP-Puro cell line has been tested for mycoplasma contamination and is certified mycoplasma free.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eThe parental A375 cell line was authenticated are certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 9 STR loci including CSF1PO, D13S317, D16S539, D5S818, D7S820, TH01, TPOX, vWA and sex chromosome marker \u003cem\u003eAmelogenin\u003c\/em\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses: \u003c\/strong\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high Fluc\/eGFP expressing cell line suitable for use as a positive control cell line in bioluminescence and fluorescence assays to verify luciferase or GFP expression respectively in your lentiviral transduced cells. \u003cem\u003eIn vivo\u003c\/em\u003e: A375 cells form tumors post implantation into immunosuppressed mice. The in vivo growth of these tumors can be monitored using noninvasive bioluminescent imaging.\u003c\/p\u003e\n\u003cp\u003eNote: In-life imaging for GFP fluorescence is not recommended due to high background autofluorescence and low light penetration. Tissues may be harvested post mortem for analysis by conventional microscopy. \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications that used associated reagents: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e: Shen et al. Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=26712908\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eBlood. 2016. March 17: 127(11): 1449-58\u003c\/a\u003e. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eCell photos:\u003c\/strong\u003e Low- and high-density cell morphology (200X)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_Website_CL085_large.png?v=1454604171\" alt=\"\" width=\"448\" height=\"336\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFlow Cytometry for eGFP: \u003c\/strong\u003eA375-Fluc-Neo\/eGFP-Puro (green) or isotype control (A375-Fluc-Puro; grey) cells were fixed with paraformaldehyde and analyzed by flow cytometry (20,000 events). \u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/FACs_for_COA_IM82_large.jpg?v=1454604346\" alt=\"\" width=\"314\" height=\"300\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLuciferase Assay: \u003c\/strong\u003e\u003cspan\u003e10\u003c\/span\u003e\u003csup\u003e4\u003c\/sup\u003e\u003cspan\u003e, 10\u003c\/span\u003e\u003csup\u003e5\u003c\/sup\u003e\u003cspan\u003e, or 10\u003c\/span\u003e\u003csup\u003e6\u003c\/sup\u003e\u003cspan\u003e cells were placed in wells of a 96-well plate and 30 μg\/mL of d-luciferin was added to the indicated wells. The plate was immediately imaged using a Xenogen IVIS Spectrum.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp style=\"padding-left: 30px;\"\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Xenogen_for_website_CL085_large.png?v=1454604179\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBioluminescent images showing growth of a subcutaneous A375-Fluc tumor in an athymic mouse\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/CL055_A375_IM39_1299_Web_large.png?v=1461444842\" alt=\"\" width=\"429\" height=\"346\"\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch5\u003e10\u003csup\u003e7\u003c\/sup\u003e A375-Fluc-Puro cells (\u003ca href=\"https:\/\/www.imanislife.com\/products\/cl055\" target=\"_blank\" title=\"A375 luciferase cell line\" rel=\"noopener noreferrer\"\u003eImanis Life catalog #CL055\u003c\/a\u003e) were injected subcutaneously into the right flanks of female NCR athymic mice. Mice were imaged at day 0 on the day of cell implantation and subsequently at days 7 and 16 using a Perkin Elmer IVIS® Spectrum system, at 10-15 minutes post intraperitoneal injection of D-luciferin at 150 mg\/kg. Tumor size was measured using calipers. Data from a representative mouse (ID#1299) is shown.\u003c\/h5\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15985050452040,"sku":"CL085-STAN","price":2100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_Website_CL085.png?v=1466612928"},{"product_id":"cl086","title":"A375-hNIS-Neo\/eGFP-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Human-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/melanoma\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMelanoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/pages\/what-is-nis\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman sodium iodide symporter (hNIS)\u003c\/a\u003e with neomycin resistance (Neo) for selection with G418 and enhanced green fluorescent protein (eGFP) with puromycin resistance for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 0.6 mg\/mL G418, 1 μg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eA375-hNIS-Neo\/eGFP-Puro is a polyclonal population of the human malignant melanoma cell line A375 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-1619.aspx\"\u003e(ATCC® CRL-1619™)\u003c\/a\u003e transduced with \u003ca href=\"\/products\/lv013\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-hNIS-IRES-Neo (LV013)\u003c\/a\u003e encoding the human sodium iodide symporter (hNIS) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene (Neo) via an internal ribosomal entry site (IRES) and \u003ca href=\"\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e encoding the enhanced green fluorescent protein (eGFP) cDNA under the spleen focus-forming virus (SFFV) promoter and the puromycin resistance gene (Puro) under the mouse phosphoglycerate kinase (PGK) promoter.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMycoplasma Testing: \u003c\/strong\u003e\u003cspan style=\"line-height: 1.4;\"\u003eThe A375-hNIS-Neo\/eGFP-Puro cell line has been tested for mycoplasma contamination and is certified mycoplasma free.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eThe parental A375 cell line was authenticated are certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 9 STR loci including CSF1PO, D13S317, D16S539, D5S818, D7S820, TH01, TPOX, vWA and sex chromosome marker \u003cem\u003eAmelogenin\u003c\/em\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high hNIS\/eGFP expressing cell line suitable for use as a positive control cell line in iodine uptake and fluorescence assays to verify NIS or GFP expression respectively in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: A375 cells form tumors post implantation into immunosuppressed mice. The in vivo growth of these tumors can be monitored using noninvasive, high-resolution 3D PET\/SPECT imaging or optical imaging for GFP.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications that used associated reagents: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ca href=\"http:\/\/www.imanislife.com\/products\/lv031\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-eGFP-PGK-Puro (LV031)\u003c\/a\u003e: Shen et al. Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=26712908\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eBlood. 2016. March 17: 127(11): 1449-58\u003c\/a\u003e. \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eCell photos:\u003c\/strong\u003e Low- and high-density cell morphology (200X)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_Website_CL086_large.png?v=1454604630\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNIS Function Assay (Iodine Uptake):\u003c\/strong\u003e Cells were incubated with \u003csup\u003e125\u003c\/sup\u003eI for 1h in the presence or absence of KClO\u003csub\u003e4\u003c\/sub\u003e, an inhibitor of iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Uptake_for_COA_IM83_large.jpg?v=1454604637\" alt=\"\"\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFlow Cytometry for eGFP: \u003c\/strong\u003eA375-hNIS-Neo\/eGFP-Puro (green) or isotype control (A375-Fluc-Puro; grey) cells were fixed with paraformaldehyde and analyzed by flow cytometry (20,000 events).\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/FACs_for_COA_IM83_large.jpg?v=1454604643\" alt=\"\"\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15985103732808,"sku":"CL086-STAN","price":2100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_Website_CL086.png?v=1466612938"},{"product_id":"cl078","title":"4T1-Fluc-Neo\/iRFP-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Line\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Breast-Cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMammary carcinoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Firefly luciferase (Fluc) with neomycin resistance (Neo) for selection with G418 and near-infrared fluorescent protein (iRFP; excitation\/emission: 690\/713nm) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e RPMI, 10% FBS, 1% Pen\/Strep, 0.1 mg\/mL G418, 2 μg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003e4T1-Fluc-Neo\/iRFP-Puro is a polyclonal population of the murine mammary carcinoma cell line 4T1 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-2539.aspx\"\u003e(ATCC® CRL-2539™)\u003c\/a\u003e transduced with 1) \u003ca href=\"\/products\/lv011\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-Fluc-P2A-Neo (LV011) \u003c\/a\u003eencoding the firefly luciferase (Fluc) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene (Neo) via a P2A sequence and 2) \u003ca href=\"\/products\/lv032\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-iRFP-P2A-Puro (LV032)\u003c\/a\u003e encoding the near-infrared fluorescent protein (iRFP) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the puromycin resistance gene (Puro) via a P2A cleavage peptide\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vectors used are self-inactivating (SIN) vectors in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMycoplasma Testing: \u003c\/strong\u003e\u003cspan style=\"line-height: 1.4;\"\u003eThe 4T1-Fluc-Neo\/iRFP-Puro cell line has been tested for mycoplasma contamination and is certified mycoplasma free.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eThe parental 4T1 cell line was authenticated and certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 27 STR loci.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high luciferase\/iRFP expressing cell line suitable for use as a positive control cell line in bioluminescence and fluorescence assays to verify luciferase or iRFP expression respectively in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: 4T1 cells form tumors post implantaton into syngenic Balb\/c mice. The in vivo growth of these tumors can be monitored using noninvasive bioluminescent imaging or noninvasive optical imaging.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eCell Morphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp style=\"text-align: left;\"\u003e\u003cimg alt=\"Microscopy shows normal 4T1 morphology in 4T1-Fluc-Neo\/iRFP-Puro cells\" src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL078_large.png?v=1454609472\" style=\"float: none;\"\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLuciferase Assay: \u003c\/strong\u003e10\u003csup\u003e4\u003c\/sup\u003e, 10\u003csup\u003e5\u003c\/sup\u003e, or 10\u003csup\u003e6\u003c\/sup\u003e cells were placed in wells of a 96-well plate and 0.3 mg of d-luciferin was added to the indicated wells. The plate was immediately imaged using a Xenogen IVIS Spectrum.\u003c\/p\u003e\n\u003cp style=\"text-align: left;\"\u003e\u003cimg alt=\"Xenogen imaging with D-luciferin substrate shows high luciferase expression in 4T1-Fluc-Neo\/iRFP-Puro cells\" src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Xenogen_for_website_CL078_large.png?v=1454609479\" style=\"float: none;\"\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFlow Cytometry for iRFP: \u003c\/strong\u003e4T1-Fluc-Neo\/iRFP-Puro (red) or isotype control (4T1-Fluc-Neo; grey) cells were fixed with paraformaldehyde and analyzed by flow cytometry (20,000 events).\u003c\/p\u003e\n\u003cp\u003e\u003cimg alt=\"Flow cytometry shows high iRFP expression in 4T1-Fluc-Neo\/iRFP-Puro cells\" src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Flow_for_COA_IM75_large.jpg?v=1454609485\" style=\"float: none;\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBioluminescent images of a subcutaneous 4T1-Fluc-Neo tumor in an athymic mouse. \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e10\u003c\/span\u003e\u003csup\u003e7\u003c\/sup\u003e\u003cspan\u003e 4T1-Fluc-Neo cells (\u003c\/span\u003e\u003ca href=\"https:\/\/www.imanislife.com\/products\/cl020-1\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eImanis Life catalog #CL020\u003c\/a\u003e\u003cspan\u003e) were\u003c\/span\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/4T1-Fluc-Neo_3876_IM114_large.png?v=1459803103\" alt=\"\" width=\"278\" height=\"308\" style=\"float: right;\"\u003e\u003cspan\u003e injected subcutaneously into the right flanks of female NCR athymic mice. Mice were imaged at day 0 on the day of cell implantation and at day 16 using a Perkin Elmer IVIS® Spectrum system, at 10-15 minutes post intraperitoneal injection of D-luciferin at 150 mg\/kg. Tumor size was measured using calipers. Data from a representative mouse (ID#3876) is shown.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e*Note: This is not an image from this cell line. 4T1-Fluc-Neo is a cell line generated from the same parental line using the same transduction protocol. \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15981463011400,"sku":"CL078-STAN","price":2100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL078.png?v=1466612858"},{"product_id":"cl108","title":"4T1-mNIS-Neo\/iRFP-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Breast-Cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMammary carcinoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Murine sodium iodide symporter (mNIS) with neomycin resistance (Neo) for selection with G418 and near-infrared fluorescent protein (iRFP; excitation\/emission: 690\/713nm) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e RPMI, 10% FBS, 1% Pen\/Strep, 0.1 mg\/mL G418, \u003cspan\u003e2\u003c\/span\u003e\u003cspan\u003e μg\/mL puromycin\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e4T1-mNIS-Neo\/iRFP-Puro is a polyclonal population of the murine mammary carcinoma cell line 4T1 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-2539.aspx\"\u003e(ATCC® CRL-2539™)\u003c\/a\u003e transduced with 1) \u003ca href=\"\/products\/lv025\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-mNIS-P2A-Neo (LV025)\u003c\/a\u003e encoding the murine sodium iodide symporter (mNIS) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene (Neo) via a P2A sequence and 2) \u003ca href=\"\/products\/lv032\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-iRFP-P2A-Puro (LV032)\u003c\/a\u003e encoding the near-infrared fluorescent protein (iRFP) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the puromycin resistance gene (Puro) via a P2A cleavage peptide\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vectors used are self-inactivating (SIN) vectors in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMycoplasma Testing: \u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe 4T1-mNIS-Neo\/iRFP-Puro cell line has been tested for mycoplasma contamination and is certified mycoplasma free.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe parental 4T1 cell line was authenticated and certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 27 STR loci.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high mNIS\/iRFP expressing cell line suitable for use as a positive control cell line in iodine uptake and fluorescence assays to verify NIS or iRFP expression respectively in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: 4T1 cells form tumors post implantation into mice. The in vivo growth of these tumors can be monitored using noninvasive, high-resolution 3D PET\/SPECT imaging or noninvasive optical imaging. Please ensure that your optical imaging systems have the correct excitation and emission filters for detection of iRFP.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL108_large.png?v=1454615418\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNIS Function Assay (Iodine Uptake):\u003c\/strong\u003e Cells were incubated with 125I for 1h in the presence or absence of KClO4, an inhibitor of NIS mediated iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter.\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Uptake_for_COA_IM106_large.jpg?v=1454615425\" alt=\"\"\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFlow Cytometry for iRFP: \u003c\/strong\u003e4T1-mNIS-Neo\/iRFP-Puro (red) or isotype control (4T1-Fluc-Neo; grey) cells were fixed with paraformaldehyde and analyzed by flow cytometry (20,000 events).\u003c\/p\u003e\n\u003cp style=\"text-align: left;\"\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Flow_for_COA_IM106_large.jpg?v=1454615437\" alt=\"\"\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15981650214984,"sku":"CL108-STAN","price":2100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL108.png?v=1466612939"},{"product_id":"cl094","title":"4T1-iRFP-Puro","description":"\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Mouse-Line\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMouse\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Breast-Cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eMammary carcinoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e Near-infrared fluorescent protein (iRFP; excitation\/emission: 690\/713nm) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e RPMI, 10% FBS, 1% Pen\/Strep, 2 μg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003e4T1-iRFP-Puro is a polyclonal population of the murine mammary carcinoma cell line 4T1 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CRL-2539.aspx\"\u003e(ATCC® CRL-2539™)\u003c\/a\u003e transduced with a lentiviral vector \u003ca href=\"\/products\/lv032\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-iRFP-P2A-Puro (LV032)\u003c\/a\u003e encoding the near-infrared fluorescent protein (iRFP) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the puromycin resistance gene (Puro) via a P2A cleavage peptide\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vectors used are self-inactivating (SIN) vectors in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMycoplasma Testing: \u003c\/strong\u003e\u003cspan style=\"line-height: 1.4;\"\u003eThe 4T1-iRFP-Puro cell line has been tested for mycoplasma contamination and is certified mycoplasma free.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eThe parental 4T1 cell line was authenticated and certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 27 STR loci.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high iRFP expressing cell line suitable for use as a positive control cell line in fluorescence assays to verify iRFP expression in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: 4T1 cells form tumors post implantation into immunocompromised or syngenic Balb\/c mice. The in vivo growth of these tumors can be monitored using noninvasive optical imaging.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cmeta charset=\"utf-8\"\u003e\n\u003cp\u003e\u003cstrong\u003eMorphology:\u003c\/strong\u003e Low- and high-density cell morphology (200x)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL094_large.png?v=1454615712\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFlow Cytometry for iRFP: \u003c\/strong\u003e4T1-iRFP-Puro (red) or control (4T1-Fluc-Neo; grey) cells were fixed with paraformaldehyde and analyzed by flow cytometry (20,000 events).\u003c\/p\u003e\n\u003cp style=\"text-align: left;\"\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Flow_for_COA_IM91_large.jpg?v=1454615718\" alt=\"\"\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15981585268808,"sku":"CL094-STAN","price":1500.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL094.png?v=1466612844"},{"product_id":"cl083","title":"A549-hNIS-Neo\/Fluc-Puro","description":"\u003cmeta charset=\"utf-8\"\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Human-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"\/collections\/cell-lines\/Lung-Cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLung Carcinoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/pages\/what-is-nis\"\u003eHuman sodium iodide symporter (hNIS)\u003c\/a\u003e with neomycin resistance (Neo) for selection with G418 and firefly luciferase (Fluc) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 0.6 mg\/mL G418, 1 μg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA549-hNIS-Neo\/Fluc-Puro is a polyclonal population of the human lung carcinoma cell line A549 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CCL-185.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CCL-185™)\u003c\/a\u003e transduced with 1) \u003ca href=\"\/products\/lv013\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-hNIS-IRES-Neo (LV013)\u003c\/a\u003e encoding the human sodium iodide symporter (hNIS) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene (Neo) via an internal ribosomal entry site (IRES) and 2) \u003ca href=\"\/products\/lv012\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-Fluc-P2A-Puro (LV012)\u003c\/a\u003e encoding firefly luciferase (Fluc) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the puromycin resistance gene (Puro) via a P2A cleavage peptide.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMycoplasma Testing: \u003c\/strong\u003eThe A549-hNIS-Neo\/Fluc-Puro cell line has been tested for mycoplasma contamination and is certified mycoplasma free.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eThe parental A549 cell line was authenticated and certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 9 STR loci including CSF1PO, D13S317, D16S539, D5S818, D7S820, TH01, TPOX, vWA and sex chromosome marker Amelogenin.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high hNIS\/luciferase expressing cell line suitable for use as a positive control cell line in iodine uptake and bioluminescence assays to verify NIS or luciferase expression respectively in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: A549 cells form metastases in the lungs of mice post systemic administration. The in vivo growth of these metastases can be monitored using noninvasive, high-resolution 3D PET\/SPECT imaging or bioluminescent imaging.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eCell photos:\u003c\/strong\u003e Low- and high-density cell morphology (200X)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL083_large.png?v=1454622063\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNIS Functional Assay (Iodine Uptake):\u003c\/strong\u003e Cells were incubated with \u003csup\u003e125\u003c\/sup\u003e\u003cspan\u003eI \u003c\/span\u003efor 1h in the presence or absence of KClO\u003csub\u003e4\u003c\/sub\u003e\u003cspan\u003e, an inhibitor of NIS-mediated iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Uptake_for_COA_IM80_large.jpg?v=1454622075\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLuciferase Assay: \u003c\/strong\u003e\u003cspan\u003e10\u003c\/span\u003e\u003csup\u003e4\u003c\/sup\u003e\u003cspan\u003e, 10\u003c\/span\u003e\u003csup\u003e5\u003c\/sup\u003e\u003cspan\u003e, or 10\u003c\/span\u003e\u003csup\u003e6\u003c\/sup\u003e\u003cspan\u003e cells were placed in wells of a 96-well plate and 30 μg\/mL of d-luciferin was added to the indicated wells. The plate was immediately imaged using a Xenogen IVIS Spectrum.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Xenogen_for_Website_CL083_large.png?v=1454622069\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBioluminescent images showing growth of a subcutaneous A549-Fluc tumor in an athymic mouse\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/CL080_A549-Fluc_IM77_Web_4878_large.png?v=1460941101\" alt=\"\" width=\"395\" height=\"302\"\u003e\u003c\/p\u003e\n\u003ch5\u003e10\u003csup\u003e7\u003c\/sup\u003e A549-Fluc-Puro cells (\u003ca href=\"https:\/\/www.imanislife.com\/products\/cl080\" target=\"_blank\" title=\"A549 luciferase firefly in vivo\" rel=\"noopener noreferrer\"\u003eImanis Life catalog #CL080\u003c\/a\u003e) were injected subcutaneously into the right flanks of female NCR athymic mice. Mice were imaged at day 0 on the day of cell implantation and subsequently at days 7 and 16 using a Perkin Elmer IVIS® Spectrum system, at 10-15 minutes post intraperitoneal injection of D-luciferin at 150 mg\/kg. Tumor size was measured using calipers. Data from a representative mouse (ID#4878) is shown.\u003c\/h5\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15985254826056,"sku":"CL083-STAN","price":2100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL083.png?v=1466613057"},{"product_id":"cl084","title":"A549-hNIS-Neo\/iRFP-Puro","description":"\u003cmeta charset=\"utf-8\"\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eSpecies:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/collections\/cell-lines\/Human-Lines\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eHuman\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell type:\u003c\/strong\u003e \u003ca href=\"\/collections\/cell-lines\/Lung-Cancer\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLung Carcinoma\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTransgenes:\u003c\/strong\u003e \u003ca href=\"http:\/\/www.imanislife.com\/pages\/what-is-nis\"\u003eHuman sodium iodide symporter (hNIS)\u003c\/a\u003e with neomycin resistance (Neo) for selection with G418 and near-infrared fluorescent protein (iRFP; excitation\/emission: 690\/713nm) with puromycin resistance (Puro) for selection with puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedia:\u003c\/strong\u003e DMEM, 10% FBS, 1% Pen\/Strep, 0.6 mg\/mL G418, 1 μg\/mL puromycin\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDescription: \u003c\/strong\u003eA549-hNIS-Neo\/iRFP-Puro is a polyclonal population of the human lung carcinoma cell line A549 \u003ca href=\"http:\/\/www.atcc.org\/products\/all\/CCL-185.aspx\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e(ATCC® CCL-185™)\u003c\/a\u003e transduced with 1) \u003ca href=\"\/products\/lv013\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-hNIS-IRES-Neo (LV013)\u003c\/a\u003e encoding the human sodium iodide symporter (hNIS) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the neomycin resistance gene (Neo) via an internal ribosomal entry site (IRES) and 2) \u003ca href=\"\/products\/lv032\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eLV-iRFP-P2A-Puro (LV032)\u003c\/a\u003e encoding the near-infrared fluorescent protein (iRFP) cDNA under the spleen focus-forming virus (SFFV) promoter linked to the puromycin resistance gene (Puro) via a P2A cleavage peptide.\u003c\/p\u003e\n\u003cp\u003eThe lentiviral vector used is a self-inactivating (SIN) vector in which the viral enhancer and promoter has been deleted. Transcription inactivation of the LTR in the SIN provirus increases biosafety by preventing mobilization by replication competent viruses and enables regulated expression of the genes from the internal promoters without \u003cem\u003ecis\u003c\/em\u003e-acting effects of the LTR (Miyoshi et al., J Virol. 1998).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMycoplasma Testing: \u003c\/strong\u003eThe A549-hNIS-Neo\/iRFP-Puro cell line has been tested for mycoplasma contamination and is certified mycoplasma free.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCell Line Authentication: \u003c\/strong\u003eThe parental A549 cell line was authenticated and certified free of interspecies cross-contamination by short tandem repeat (STR) profiling with 9 STR loci including CSF1PO, D13S317, D16S539, D5S818, D7S820, TH01, TPOX, vWA and sex chromosome marker \u003cem\u003eAmelogenin\u003c\/em\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRecommended uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vitro\u003c\/em\u003e: This is a high hNIS\/iRFP expressing cell line suitable for use as a positive control cell line in iodine uptake and fluorescence assays to verify NIS or iRFP expression respectively in your lentiviral transduced cells.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eIn vivo\u003c\/em\u003e: A549 cells form metastases in the lungs of mice post systemic administration. The in vivo growth of these metastases can be monitored using noninvasive, high-resolution 3D PET\/SPECT imaging or noninvasive optical imaging for iRFP fluorescence.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eReferences on NIS imaging\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e1. Fruthwirth et al. A whole body dual modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment responses in different. microenvironments. \u003ca href=\"http:\/\/jnm.snmjournals.org\/content\/55\/4\/686.long\" target=\"_blank\" rel=\"noopener noreferrer\"\u003eJ. Nucl. Med 2014. 55(4): 686-94.\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003e2. Penheiter et al. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral and cell-based therapies. \u003ca href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22263922\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\u003cspan class=\"jrnl\" title=\"Current gene therapy\"\u003eCurr Gene Ther\u003c\/span\u003e\u003cspan\u003e. 2012, 12(1):33-47.\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-50\"\u003e\n\u003cp\u003e\u003cstrong\u003eCell photos:\u003c\/strong\u003e Low- and high-density cell morphology (200X)\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL084_large.png?v=1454622429\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNIS Functional Assay (Iodine Uptake):\u003c\/strong\u003e Cells were incubated with \u003csup\u003e125\u003c\/sup\u003e\u003cspan\u003eI \u003c\/span\u003efor 1h in the presence or absence of KClO\u003csub\u003e4\u003c\/sub\u003e\u003cspan\u003e, an inhibitor of NIS-mediated iodine uptake. Radioiodine concentrated within the cells was measured with a gamma counter.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Uptake_for_COA_IM81_large.jpg?v=1454622435\" alt=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFlow Cytometry for iRFP: \u003c\/strong\u003eA549-hNIS-Neo\/iRFP-Puro (red) or control (A549-Fluc-Puro; grey) cells were fixed with paraformaldehyde and analyzed by flow cytometry (20,000 events).\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Flow_for_COA_IM81_large.jpg?v=1454622441\" alt=\"\"\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Imanis Life Sciences","offers":[{"title":"Frozen \/ Standard","offer_id":15985284284488,"sku":"CL084-STAN","price":2100.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0683\/0295\/products\/Photos_for_website_CL084.png?v=1466613049"}],"url":"https:\/\/imanis-life-sciences-4.myshopify.com\/collections\/cell-lines.oembed?page=2","provider":"Imanis Life Sciences","version":"1.0","type":"link"}